Immunometabolism: new insights and lessons from antigen-directed cellular immune responses

1.

Emambokus N, Granger A, Mott R, Helenius T (2017) The immunometabolism choreography. Cell Metab 26(1):1. https://doi.org/10.1016/j.cmet.2017.06.020 CrossRefPubMed

2.

Pearce EJ, Pearce EL (2017) Immunometabolism in 2017: driving immunity: all roads lead to metabolism. Nat Rev Immunol. https://doi.org/10.1038/nri.2017.139

3.

Mathis D, Shoelson SE (2011) Immunometabolism: an emerging frontier. Nat Rev Immunol 11(2):81. https://doi.org/10.1038/nri2922 CrossRefPubMedPubMedCentral

4.

O’Neill LA, Kishton RJ, Rathmell J (2016) A guide to immunometabolism for immunologists. Nat Rev Immunol 16(9):553–565. https://doi.org/10.1038/nri.2016.70 CrossRefPubMedPubMedCentral

5.

O’Neill L (2017) Immunometabolism and the land of milk and honey. Nat Rev Immunol 17(4):217. https://doi.org/10.1038/nri.2017.22 CrossRefPubMed

6.

Loftus RM, Finlay DK (2016) Immunometabolism: cellular metabolism turns immune regulator. J Biol Chem 291(1):1–10. https://doi.org/10.1074/jbc.R115.693903 CrossRefPubMed

7.

Kelly B, O’Neill LA (2015) Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res 25(7):771–784. https://doi.org/10.1038/cr.2015.68 CrossRefPubMedPubMedCentral

8.

Cao Y, Rathmell JC, Macintyre AN (2014) Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to metabolic inhibition in CD8 versus CD4 T cells. PLoS One 9(8):e104104. https://doi.org/10.1371/journal.pone.0104104 CrossRefPubMedPubMedCentral

9.

Rosa Neto JC, Lira FS, Roy S, Festuccia W (2017) Immunometabolism: molecular mechanisms, diseases, and therapies 2016. Mediat Inflamm 2017:8230298. https://doi.org/10.1155/2017/8230298 CrossRef

10.

Schertzer JD, Steinberg GR (2014) Immunometabolism: the interface of immune and metabolic responses in disease. Immunol Cell Biol 92(4):303. https://doi.org/10.1038/icb.2014.12 CrossRefPubMed

11.

Leech JM, Dhariwala MO, Lowe MM, Chu K, Merana GR, Cornuot C, Weckel A, Ma JM, Leitner EG, Gonzalez JR, Vasquez KS, Diep BA, Scharschmidt TC (2019) Toxin-triggered interleukin-1 receptor signaling enables early-life discrimination of pathogenic versus commensal skin bacteria. Cell Host Microbe 26(6):795–809 e795. https://doi.org/10.1016/j.chom.2019.10.007 CrossRefPubMedPubMedCentral

12.

Rood JE, Stuart T, Ghazanfar S, Biancalani T, Fisher E, Butler A, Hupalowska A, Gaffney L, Mauck W, Eraslan G, Marioni JC, Regev A, Satija R (2019) Toward a common coordinate framework for the human body. Cell 179(7):1455–1467. https://doi.org/10.1016/j.cell.2019.11.019 CrossRefPubMedPubMedCentral

13.

Pearce EL, Pearce EJ (2013) Metabolic pathways in immune cell activation and quiescence. Immunity 38(4):633–643. https://doi.org/10.1016/j.immuni.2013.04.005 CrossRefPubMedPubMedCentral

14.

Norata GD, Caligiuri G, Chavakis T, Matarese G, Netea MG, Nicoletti A, O’Neill LA, Marelli-Berg FM (2015) The cellular and molecular basis of translational immunometabolism. Immunity 43(3):421–434. https://doi.org/10.1016/j.immuni.2015.08.023 CrossRefPubMed

15.

Puleston DJ, Villa M, Pearce EL (2017) Ancillary activity: beyond core metabolism in immune cells. Cell Metab 26(1):131–141. https://doi.org/10.1016/j.cmet.2017.06.019 CrossRefPubMedPubMedCentral

16.

Prochnicki T, Latz E (2017) Inflammasomes on the crossroads of innate immune recognition and metabolic control. Cell Metab 26(1):71–93. https://doi.org/10.1016/j.cmet.2017.06.018 CrossRefPubMed

17.

Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG, Choi Y (2009) Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460(7251):103–107. https://doi.org/10.1038/nature08097 CrossRefPubMedPubMedCentral

18.

van der Windt GJ, Everts B, Chang CH, Curtis JD, Freitas TC, Amiel E, Pearce EJ, Pearce EL (2012) Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity 36(1):68–78. https://doi.org/10.1016/j.immuni.2011.12.007 CrossRefPubMed

19.

O’Sullivan D, van der Windt GJ, Huang SC, Curtis JD, Chang CH, Buck MD, Qiu J, Smith AM, Lam WY, DiPlato LM, Hsu FF, Birnbaum MJ, Pearce EJ, Pearce EL (2014) Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 41(1):75–88. https://doi.org/10.1016/j.immuni.2014.06.005 CrossRefPubMedPubMedCentral

20.

Lochner M, Berod L, Sparwasser T (2015) Fatty acid metabolism in the regulation of T cell function. Trends Immunol 36(2):81–91. https://doi.org/10.1016/j.it.2014.12.005 CrossRefPubMed

21.

Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, Luo C, O’Malley JT, Gehad A, Teague JE, Divito SJ, Fuhlbrigge R, Puigserver P, Krueger JG, Hotamisligil GS, Clark RA, Kupper TS (2017) Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543(7644):252–256. https://doi.org/10.1038/nature21379 CrossRefPubMedPubMedCentral

22.

Raud B, Roy DG, Divakaruni AS, Tarasenko TN, Franke R, Ma EH, Samborska B, Hsieh WY, Wong AH, Stuve P, Arnold-Schrauf C, Guderian M, Lochner M, Rampertaap S, Romito K, Monsale J, Bronstrup M, Bensinger SJ, Murphy AN, McGuire PJ, Jones RG, Sparwasser T, Berod L (2018) Etomoxir actions on regulatory and memory T cells are independent of Cpt1a-mediated fatty acid oxidation. Cell Metab 28(3):504–515.e507. https://doi.org/10.1016/j.cmet.2018.06.002 CrossRefPubMedPubMedCentral

23.

Mills EL, O’Neill LA (2016) Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal. Eur J Immunol 46(1):13–21. https://doi.org/10.1002/eji.201445427 CrossRefPubMed

24.

Zhang L, Romero P (2018) Metabolic control of CD8(+) T cell fate decisions and antitumor immunity. Trends Mol Med 24(1):30–48. https://doi.org/10.1016/j.molmed.2017.11.005 CrossRefPubMed

25.

Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39(1):1–10. https://doi.org/10.1016/j.immuni.2013.07.012 CrossRefPubMed

26.

Andrejeva G, Rathmell JC (2017) Similarities and distinctions of cancer and immune metabolism in inflammation and tumors. Cell Metab 26(1):49–70. https://doi.org/10.1016/j.cmet.2017.06.004 CrossRefPubMedPubMedCentral

27.

Cohen R, Neuzillet C, Tijeras-Raballand A, Faivre S, de Gramont A, Raymond E (2015) Targeting cancer cell metabolism in pancreatic adenocarcinoma. Oncotarget 6(19):16832–16847. https://doi.org/10.18632/oncotarget.4160 CrossRefPubMedPubMedCentral

28.

Arsenault RJ, Kogut MH (2015) Immunometabolism and the kinome peptide array: a new perspective and tool for the study of gut health. Front Vet Sci 2:44. https://doi.org/10.3389/fvets.2015.00044 CrossRefPubMedPubMedCentral

29.

McPhee JB, Schertzer JD (2015) Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation. Clin Sci (Lond) 129(12):1083–1096. https://doi.org/10.1042/cs20150431 CrossRef

30.

Ponton F, Wilson K, Cotter SC, Raubenheimer D, Simpson SJ (2011) Nutritional immunology: a multi-dimensional approach. PLoS Pathog 7(12):e1002223. https://doi.org/10.1371/journal.ppat.1002223 CrossRefPubMedPubMedCentral

31.

Zapatera B, Prados A, Gomez-Martinez S, Marcos A (2015) Immunonutrition: methodology and applications. Nutr Hosp 31(Suppl 3):145–154. https://doi.org/10.3305/nh.2015.31.sup3.8762 CrossRefPubMed

32.

Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, Giamarellos-Bourboulis EJ, Martens JH, Rao NA, Aghajanirefah A, Manjeri GR, Li Y, Ifrim DC, Arts RJ, van der Veer BM, Deen PM, Logie C, O’Neill LA, Willems P, van de Veerdonk FL, van der Meer JW, Ng A, Joosten LA, Wijmenga C, Stunnenberg HG, Xavier RJ, Netea MG (2014) mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 345(6204):1250684. https://doi.org/10.1126/science.1250684 CrossRefPubMedPubMedCentral

33.

Palsson-McDermott EM, O’Neill LA (2013) The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays 35(11):965–973. https://doi.org/10.1002/bies.201300084 CrossRefPubMed

34.

Fadaka A, Ajiboye B, Ojo O, Adewale O, Olayide I, Emuowhochere R (2017) Biology of glucose metabolization in cancer cells. J Oncol Sci 3(2):45–51. https://doi.org/10.1016/j.jons.2017.06.002 CrossRef

35.

Jiang B (2017) Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment. Genes Dis 4(1):25–27. https://doi.org/10.1016/j.gendis.2017.02.003 CrossRefPubMedPubMedCentral

36.

Liao Y (2017) Cancer metabolism as we know it today: a prologue to a special issue of cancer metabolism. Genes Dis 4(1):4–6. https://doi.org/10.1016/j.gendis.2017.02.001 CrossRefPubMedPubMedCentral

37.

Tan Z, Xie N, Cui H, Moellering DR, Abraham E, Thannickal VJ, Liu G (2015) Pyruvate dehydrogenase kinase 1 participates in macrophage polarization via regulating glucose metabolism. J Immunol 194(12):6082–6089. https://doi.org/10.4049/jimmunol.1402469 CrossRefPubMed

38.

Palsson-McDermott EM, Curtis AM, Goel G, Lauterbach MA, Sheedy FJ, Gleeson LE, van den Bosch MW, Quinn SR, Domingo-Fernandez R, Johnston DG, Jiang JK, Israelsen WJ, Keane J, Thomas C, Clish C, Vander Heiden M, Xavier RJ, O’Neill LA (2015) Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the Warburg effect in LPS-activated macrophages. Cell Metab 21(1):65–80. https://doi.org/10.1016/j.cmet.2014.12.005 CrossRefPubMedPubMedCentral

39.

Shapiro H, Lutaty A, Ariel A (2011) Macrophages, meta-inflammation, and immuno-metabolism. ScientificWorldJournal 11:2509–2529. https://doi.org/10.1100/2011/397971 CrossRefPubMedPubMedCentral

40.

Curi R, de Siqueira MR, de Campos Crispin LA, Norata GD, Sampaio SC, Newsholme P (2017) A past and present overview of macrophage metabolism and functional outcomes. Clin Sci (Lond) 131(12):1329–1342. https://doi.org/10.1042/cs20170220 CrossRef

41.

Ryan DG, O’Neill LAJ (2017) Krebs cycle rewired for macrophage and dendritic cell effector functions. FEBS Lett 591(19):2992–3006. https://doi.org/10.1002/1873-3468.12744 CrossRefPubMed

42.

Almeida L, Lochner M, Berod L, Sparwasser T (2016) Metabolic pathways in T cell activation and lineage differentiation. Semin Immunol 28(5):514–524. https://doi.org/10.1016/j.smim.2016.10.009 CrossRefPubMed

43.

Stincone A, Prigione A, Cramer T, Wamelink MM, Campbell K, Cheung E, Olin-Sandoval V, Gruning NM, Kruger A, Tauqeer Alam M, Keller MA, Breitenbach M, Brindle KM, Rabinowitz JD, Ralser M (2015) The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc 90(3):927–963. https://doi.org/10.1111/brv.12140 CrossRefPubMed

44.

Barcia-Vieitez R, Ramos-Martinez JI (2014) The regulation of the oxidative phase of the pentose phosphate pathway: new answers to old problems. IUBMB Life 66(11):775–779. https://doi.org/10.1002/iub.1329 CrossRefPubMed

45.

Nagy C, Haschemi A (2015) Time and demand are two critical dimensions of immunometabolism: the process of macrophage activation and the pentose phosphate pathway. Front Immunol 6:164. https://doi.org/10.3389/fimmu.2015.00164 CrossRefPubMedPubMedCentral

46.

Akram M (2014) Citric acid cycle and role of its intermediates in metabolism. Cell Biochem Biophys 68(3):475–478. https://doi.org/10.1007/s12013-013-9750-1 CrossRefPubMed

47.

Berod L, Friedrich C, Nandan A, Freitag J, Hagemann S, Harmrolfs K, Sandouk A, Hesse C, Castro CN, Bahre H, Tschirner SK, Gorinski N, Gohmert M, Mayer CT, Huehn J, Ponimaskin E, Abraham WR, Muller R, Lochner M, Sparwasser T (2014) De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med 20(11):1327–1333. https://doi.org/10.1038/nm.3704 CrossRefPubMed

48.

Alvarez-Curto E, Milligan G (2016) Metabolism meets immunity: the role of free fatty acid receptors in the immune system. Biochem Pharmacol 114:3–13. https://doi.org/10.1016/j.bcp.2016.03.017 CrossRefPubMed

49.

Namgaladze D, Brune B (2016) Macrophage fatty acid oxidation and its roles in macrophage polarization and fatty acid-induced inflammation. Biochim Biophys Acta 1861(11):1796–1807. https://doi.org/10.1016/j.bbalip.2016.09.002 CrossRefPubMed

50.

Holecek M, Vodenicarovova M, Siman P (2017) Acute effects of phenylbutyrate on glutamine, branched-chain amino acid and protein metabolism in skeletal muscles of rats. Int J Exp Pathol 98(3):127–133. https://doi.org/10.1111/iep.12231 CrossRefPubMedPubMedCentral

51.

Cruzat V, Macedo Rogero M, Noel Keane K, Curi R, Newsholme P (2018) Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients 10(11). https://doi.org/10.3390/nu10111564

52.

Ren W, Wang K, Yin J, Chen S, Liu G, Tan B, Wu G, Bazer FW, Peng Y, Yin Y (2016) Glutamine-induced secretion of intestinal secretory immunoglobulin A: a mechanistic perspective. Front Immunol 7:503. https://doi.org/10.3389/fimmu.2016.00503 CrossRefPubMedPubMedCentral

53.

Sartori T, Galvao Dos Santos G, Nogueira-Pedro A, Makiyama E, Rogero MM, Borelli P, Fock RA (2018) Effects of glutamine, taurine and their association on inflammatory pathway markers in macrophages. Inflammopharmacology 26(3):829–838. https://doi.org/10.1007/s10787-017-0406-4 CrossRefPubMed

54.

Moinard C, Caldefie-Chezet F, Walrand S, Vasson MP, Cynober L (2002) Evidence that glutamine modulates respiratory burst in stressed rat polymorphonuclear cells through its metabolism into arginine. Br J Nutr 88(6):689–695. https://doi.org/10.1079/bjn2002724 CrossRefPubMed

55.

Carr EL, Kelman A, Wu GS, Gopaul R, Senkevitch E, Aghvanyan A, Turay AM, Frauwirth KA (2010) Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J Immunol 185(2):1037–1044. https://doi.org/10.4049/jimmunol.0903586 CrossRefPubMed

56.

Kim SH, Roszik J, Grimm EA, Ekmekcioglu S (2018) Impact of L-arginine metabolism on immune response and anticancer immunotherapy. Front Oncol 8:67. https://doi.org/10.3389/fonc.2018.00067 CrossRefPubMedPubMedCentral

57.

Geiger R, Rieckmann JC, Wolf T, Basso C, Feng Y, Fuhrer T, Kogadeeva M, Picotti P, Meissner F, Mann M, Zamboni N, Sallusto F, Lanzavecchia A (2016) L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167(3):829–842.e813. https://doi.org/10.1016/j.cell.2016.09.031 CrossRefPubMedPubMedCentral

58.

Duque-Correa MA, Kuhl AA, Rodriguez PC, Zedler U, Schommer-Leitner S, Rao M, Weiner J 3rd, Hurwitz R, Qualls JE, Kosmiadi GA, Murray PJ, Kaufmann SH, Reece ST (2014) Macrophage arginase-1 controls bacterial growth and pathology in hypoxic tuberculosis granulomas. Proc Natl Acad Sci U S A 111(38):E4024–E4032. https://doi.org/10.1073/pnas.1408839111 CrossRefPubMedPubMedCentral

59.

Rodriguez PC, Ochoa AC, Al-Khami AA (2017) Arginine metabolism in myeloid cells shapes innate and adaptive immunity. Front Immunol 8:93. https://doi.org/10.3389/fimmu.2017.00093 CrossRefPubMedPubMedCentral

60.

Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC (2002) Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem 277(24):21123–21129. https://doi.org/10.1074/jbc.M110675200 CrossRefPubMed

61.

Korrer MJ, Zhang Y, Routes JM (2014) Possible role of arginase-1 in concomitant tumor immunity. PLoS One 9(3):e91370. https://doi.org/10.1371/journal.pone.0091370 CrossRefPubMedPubMedCentral

62.

Saligan LN, Lukkahatai N, Zhang ZJ, Cheung CW, Wang XM (2018) Altered Cd8+ T lymphocyte response triggered by arginase 1: implication for fatigue intensification during localized radiation therapy in prostate cancer patients. Neuropsychiatry 8(4):1249–1262. https://doi.org/10.4172/Neuropsychiatry.1000454 CrossRefPubMedPubMedCentral

63.

Rodriguez PC, Ochoa AC (2008) Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 222:180–191. https://doi.org/10.1111/j.1600-065X.2008.00608.x CrossRefPubMedPubMedCentral

64.

Raber P, Ochoa AC, Rodriguez PC (2012) Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives. Immunol Investig 41(6–7):614–634. https://doi.org/10.3109/08820139.2012.680634 CrossRef

65.

Wu H, Gong J, Liu Y (2018) Indoleamine 2, 3-dioxygenase regulation of immune response (review). Mol Med Rep 17(4):4867–4873. https://doi.org/10.3892/mmr.2018.8537 CrossRefPubMed

66.

Brochez L, Chevolet I, Kruse V (2017) The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy. Eur J Cancer 76:167–182. https://doi.org/10.1016/j.ejca.2017.01.011 CrossRefPubMed

67.

Wang XF, Wang HS, Wang H, Zhang F, Wang KF, Guo Q, Zhang G, Cai SH, Du J (2014) The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: focus on macrophage polarization of THP-1 cells. Cell Immunol 289(1–2):42–48. https://doi.org/10.1016/j.cellimm.2014.02.005 CrossRefPubMed

68.

Husain Z, Huang Y, Seth P, Sukhatme VP (2013) Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J Immunol 191(3):1486–1495. https://doi.org/10.4049/jimmunol.1202702 CrossRefPubMed

69.

Hirschhaeuser F, Sattler UG, Mueller-Klieser W (2011) Lactate: a metabolic key player in cancer. Cancer Res 71(22):6921–6925. https://doi.org/10.1158/0008-5472.can-11-1457 CrossRefPubMed

70.

Haas R, Smith J, Rocher-Ros V, Nadkarni S, Montero-Melendez T, D’Acquisto F, Bland EJ, Bombardieri M, Pitzalis C, Perretti M, Marelli-Berg FM, Mauro C (2015) Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol 13(7):e1002202. https://doi.org/10.1371/journal.pbio.1002202 CrossRefPubMedPubMedCentral

71.

Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029–1033. https://doi.org/10.1126/science.1160809 CrossRefPubMedPubMedCentral

72.

Vazquez A, Liu J, Zhou Y, Oltvai ZN (2010) Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. BMC Syst Biol 4:58. https://doi.org/10.1186/1752-0509-4-58 CrossRefPubMedPubMedCentral

73.

Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, Chmielewski K, Stewart KM, Ashall J, Everts B, Pearce EJ, Driggers EM, Artyomov MN (2015) Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42(3):419–430. https://doi.org/10.1016/j.immuni.2015.02.005 CrossRefPubMed

74.

Epstein T, Gatenby RA, Brown JS (2017) The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand. PLoS One 12(9):e0185085. https://doi.org/10.1371/journal.pone.0185085 CrossRefPubMedPubMedCentral

75.

Lu J, Tan M, Cai Q (2015) The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett 356(2 Pt A):156–164. https://doi.org/10.1016/j.canlet.2014.04.001 CrossRefPubMed

76.

Zhu L, Zhao Q, Yang T, Ding W, Zhao Y (2015) Cellular metabolism and macrophage functional polarization. Int Rev Immunol 34(1):82–100. https://doi.org/10.3109/08830185.2014.969421 CrossRefPubMed

77.

Van den Bossche J, O’Neill LA, Menon D (2017) Macrophage immunometabolism: where are we (going)? Trends Immunol 38(6):395–406. https://doi.org/10.1016/j.it.2017.03.001 CrossRefPubMed

78.

Torres A, Makowski L, Wellen KE (2016) Immunometabolism: metabolism fine-tunes macrophage activation. Elife 5. https://doi.org/10.7554/eLife.14354

79.

Diskin C, Palsson-McDermott EM (2018) Metabolic modulation in macrophage effector function. Front Immunol 9:270. https://doi.org/10.3389/fimmu.2018.00270 CrossRefPubMedPubMedCentral

80.

Zhou D, Huang C, Lin Z, Zhan S, Kong L, Fang C, Li J (2014) Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways. Cell Signal 26(2):192–197. https://doi.org/10.1016/j.cellsig.2013.11.004 CrossRefPubMed

81.

Artyomov MN, Sergushichev A, Schilling JD (2016) Integrating immunometabolism and macrophage diversity. Semin Immunol 28(5):417–424. https://doi.org/10.1016/j.smim.2016.10.004 CrossRefPubMedPubMedCentral

82.

Biswas SK, Mantovani A (2012) Orchestration of metabolism by macrophages. Cell Metab 15(4):432–437. https://doi.org/10.1016/j.cmet.2011.11.013 CrossRefPubMed

83.

Bosca L, Gonzalez-Ramos S, Prieto P, Fernandez-Velasco M, Mojena M, Martin-Sanz P, Alemany S (2015) Metabolic signatures linked to macrophage polarization: from glucose metabolism to oxidative phosphorylation. Biochem Soc Trans 43(4):740–744. https://doi.org/10.1042/bst20150107 CrossRefPubMed

84.

O’Neill LA (2015) A broken Krebs cycle in macrophages. Immunity 42(3):393–394. https://doi.org/10.1016/j.immuni.2015.02.017 CrossRefPubMed

85.

Lirk P, Hoffmann G, Rieder J (2002) Inducible nitric oxide synthase—time for reappraisal. Curr Drug Targets Inflamm Allergy 1(1):89–108CrossRefPubMed

86.

Rath M, Muller I, Kropf P, Closs EI, Munder M (2014) Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Front Immunol 5:532. https://doi.org/10.3389/fimmu.2014.00532 CrossRefPubMedPubMedCentral

87.

Starling S (2017) Immunometabolism: T cells activate the fear. Nat Rev Immunol 17(12):730–731. https://doi.org/10.1038/nri.2017.126 CrossRefPubMed

88.

MacIver NJ, Michalek RD, Rathmell JC (2013) Metabolic regulation of T lymphocytes. Annu Rev Immunol 31:259–283. https://doi.org/10.1146/annurev-immunol-032712-095956 CrossRefPubMedPubMedCentral

89.

Chen H, Yang T, Zhu L, Zhao Y (2015) Cellular metabolism on T-cell development and function. Int Rev Immunol 34(1):19–33. https://doi.org/10.3109/08830185.2014.902452 CrossRefPubMed

90.

Waickman AT, Powell JD (2012) mTOR, metabolism, and the regulation of T-cell differentiation and function. Immunol Rev 249(1):43–58. https://doi.org/10.1111/j.1600-065X.2012.01152.x CrossRefPubMedPubMedCentral

91.

Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, Chi H (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208(7):1367–1376. https://doi.org/10.1084/jem.20110278 CrossRefPubMedPubMedCentral

92.

Bayes HK, Ritchie ND, Evans TJ (2016) Interleukin-17 is required for control of chronic lung infection caused by Pseudomonas aeruginosa. Infect Immun 84(12):3507–3516. https://doi.org/10.1128/iai.00717-16 CrossRefPubMedPubMedCentral

93.

Gopal R, Monin L, Slight S, Uche U, Blanchard E, Fallert Junecko BA, Ramos-Payan R, Stallings CL, Reinhart TA, Kolls JK, Kaushal D, Nagarajan U, Rangel-Moreno J, Khader SA (2014) Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog 10(5):e1004099. https://doi.org/10.1371/journal.ppat.1004099 CrossRefPubMedPubMedCentral

94.

Lereclus E, Tout M, Girault A, Baroukh N, Caulet M, Borg C, Bouche O, Ternant D, Paintaud G, Lecomte T, Raoul W (2017) A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen. BMC Cancer 17(1):220. https://doi.org/10.1186/s12885-017-3210-z CrossRefPubMedPubMedCentral

95.

Fabre JAS, Giustinniani J, Garbar C, Merrouche Y, Antonicelli F, Bensussan A (2018) The interleukin-17 family of cytokines in breast cancer. Int J Mol Sci 19(12). https://doi.org/10.3390/ijms19123880

96.

Doughty CA, Bleiman BF, Wagner DJ, Dufort FJ, Mataraza JM, Roberts MF, Chiles TC (2006) Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107(11):4458–4465. https://doi.org/10.1182/blood-2005-12-4788 CrossRefPubMedPubMedCentral

97.

Caro-Maldonado A, Wang R, Nichols AG, Kuraoka M, Milasta S, Sun LD, Gavin AL, Abel ED, Kelsoe G, Green DR, Rathmell JC (2014) Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J Immunol 192(8):3626–3636. https://doi.org/10.4049/jimmunol.1302062 CrossRefPubMed

98.

O’Neill LA, Pearce EJ (2016) Immunometabolism governs dendritic cell and macrophage function. J Exp Med 213(1):15–23. https://doi.org/10.1084/jem.20151570 CrossRefPubMedPubMedCentral

99.

Al-Khami AA, Rodriguez PC, Ochoa AC (2017) Energy metabolic pathways control the fate and function of myeloid immune cells. J Leukoc Biol 102(2):369–380. https://doi.org/10.1189/jlb.1VMR1216-535R CrossRefPubMedPubMedCentral

100.

Pearce EJ, Everts B (2015) Dendritic cell metabolism. Nat Rev Immunol 15(1):18–29. https://doi.org/10.1038/nri3771 CrossRefPubMedPubMedCentral

101.

Jantsch J, Chakravortty D, Turza N, Prechtel AT, Buchholz B, Gerlach RG, Volke M, Glasner J, Warnecke C, Wiesener MS, Eckardt KU, Steinkasserer A, Hensel M, Willam C (2008) Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol 180(7):4697–4705. https://doi.org/10.4049/jimmunol.180.7.4697 CrossRefPubMed

102.

Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG, Pearce EJ (2010) Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood 115(23):4742–4749. https://doi.org/10.1182/blood-2009-10-249540 CrossRefPubMedPubMedCentral

103.

Sim WJ, Ahl PJ, Connolly JE (2016) Metabolism is central to tolerogenic dendritic cell function. Mediat Inflamm 2016:2636701. https://doi.org/10.1155/2016/2636701 CrossRef

104.

Everts B, Amiel E, Huang SC, Smith AM, Chang CH, Lam WY, Redmann V, Freitas TC, Blagih J, van der Windt GJ, Artyomov MN, Jones RG, Pearce EL, Pearce EJ (2014) TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation. Nat Immunol 15(4):323–332. https://doi.org/10.1038/ni.2833 CrossRefPubMedPubMedCentral

105.

Pantel A, Teixeira A, Haddad E, Wood EG, Steinman RM, Longhi MP (2014) Direct type I IFN but not MDA5/TLR3 activation of dendritic cells is required for maturation and metabolic shift to glycolysis after poly IC stimulation. PLoS Biol 12(1):e1001759. https://doi.org/10.1371/journal.pbio.1001759 CrossRefPubMedPubMedCentral

106.

Thwe PM, Amiel E (2018) The role of nitric oxide in metabolic regulation of dendritic cell immune function. Cancer Lett 412:236–242. https://doi.org/10.1016/j.canlet.2017.10.032 CrossRefPubMed

107.

Mondanelli G, Bianchi R, Pallotta MT, Orabona C, Albini E, Iacono A, Belladonna ML, Vacca C, Fallarino F, Macchiarulo A, Ugel S, Bronte V, Gevi F, Zolla L, Verhaar A, Peppelenbosch M, Mazza EMC, Bicciato S, Laouar Y, Santambrogio L, Puccetti P, Volpi C, Grohmann U (2017) A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells. Immunity 46(2):233–244. https://doi.org/10.1016/j.immuni.2017.01.005 CrossRefPubMedPubMedCentral

108.

Kedia-Mehta N, Finlay DK (2019) Competition for nutrients and its role in controlling immune responses. Nat Commun 10(1):2123. https://doi.org/10.1038/s41467-019-10015-4 CrossRefPubMedPubMedCentral

109.

Cascone T, McKenzie JA, Mbofung RM, Punt S, Wang Z, Xu C, Williams LJ, Wang Z, Bristow CA, Carugo A, Peoples MD, Li L, Karpinets T, Huang L, Malu S, Creasy C, Leahey SE, Chen J, Chen Y, Pelicano H, Bernatchez C, Gopal YNV, Heffernan TP, Hu J, Wang J, Amaria RN, Garraway LA, Huang P, Yang P, Wistuba II, Woodman SE, Roszik J, Davis RE, Davies MA, Heymach JV, Hwu P, Peng W (2018) Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy. Cell Metab 27(5):977–987.e974. https://doi.org/10.1016/j.cmet.2018.02.024 CrossRefPubMedPubMedCentral

110.

Bowden SD, Rowley G, Hinton JC, Thompson A (2009) Glucose and glycolysis are required for the successful infection of macrophages and mice by Salmonella enterica serovar Typhimurium. Infect Immun 77(7):3117–3126. https://doi.org/10.1128/iai.00093-09 CrossRefPubMedPubMedCentral

111.

Thai M, Thaker SK, Feng J, Du Y, Hu H, Ting Wu T, Graeber TG, Braas D, Christofk HR (2015) MYC-induced reprogramming of glutamine catabolism supports optimal virus replication. Nat Commun 6:8873. https://doi.org/10.1038/ncomms9873 CrossRefPubMed

112.

Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC (2015) Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep 42(4):841–851. https://doi.org/10.1007/s11033-015-3858-x CrossRefPubMed

113.

Dang CV, Kim JW (2018) Convergence of cancer metabolism and immunity: an overview. Biomol Ther 26(1):4–9. https://doi.org/10.4062/biomolther.2017.194 CrossRef

114.

Renner K, Singer K, Koehl GE, Geissler EK, Peter K, Siska PJ, Kreutz M (2017) Metabolic hallmarks of tumor and immune cells in the tumor microenvironment. Front Immunol 8:248. https://doi.org/10.3389/fimmu.2017.00248 CrossRefPubMedPubMedCentral

115.

Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8(6):519–530. https://doi.org/10.1085/jgp.8.6.519 CrossRefPubMedPubMedCentral

116.

Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 11(5):325–337. https://doi.org/10.1038/nrc3038 CrossRefPubMed

117.

Yun J, Rago C, Cheong I, Pagliarini R, Angenendt P, Rajagopalan H, Schmidt K, Willson JK, Markowitz S, Zhou S, Diaz LA Jr, Velculescu VE, Lengauer C, Kinzler KW, Vogelstein B, Papadopoulos N (2009) Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science 325(5947):1555–1559. https://doi.org/10.1126/science.1174229 CrossRefPubMedPubMedCentral

118.

Lee N, Kim D (2016) Cancer metabolism: fueling more than just growth. Mol Cell 39(12):847–854. https://doi.org/10.14348/molcells.2016.0310 CrossRef

119.

Huang R, Zong X (2017) Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: mechanisms in cancer progression. Crit Rev Oncol Hematol 115:13–22. https://doi.org/10.1016/j.critrevonc.2017.04.005 CrossRefPubMed

120.

Corbet C, Feron O (2017) Tumour acidosis: from the passenger to the driver’s seat. Nat Rev Cancer 17(10):577–593. https://doi.org/10.1038/nrc.2017.77 CrossRefPubMed

121.

Damaghi M, Tafreshi NK, Lloyd MC, Sprung R, Estrella V, Wojtkowiak JW, Morse DL, Koomen JM, Bui MM, Gatenby RA, Gillies RJ (2015) Chronic acidosis in the tumour microenvironment selects for overexpression of LAMP2 in the plasma membrane. Nat Commun 6:8752. https://doi.org/10.1038/ncomms9752 CrossRefPubMed

122.

Luo F, Zou Z, Liu X, Ling M, Wang Q, Wang Q, Lu L, Shi L, Liu Y, Liu Q, Zhang A (2017) Enhanced glycolysis, regulated by HIF-1alpha via MCT-4, promotes inflammation in arsenite-induced carcinogenesis. Carcinogenesis 38(6):615–626. https://doi.org/10.1093/carcin/bgx034 CrossRefPubMed

123.

Lien S, Lowman HB (2008) Therapeutic anti-VEGF antibodies. Handb Exp Pharmacol 181:131–150. https://doi.org/10.1007/978-3-540-73259-4_6 CrossRef

124.

Ueda S, Saeki T, Osaki A, Yamane T, Kuji I (2017) Bevacizumab induces acute hypoxia and cancer progression in patients with refractory breast cancer: multimodal functional imaging and multiplex cytokine analysis. Clin Cancer Res 23(19):5769–5778. https://doi.org/10.1158/1078-0432.Ccr-17-0874 CrossRefPubMed

125.

Cheong H (2015) Integrating autophagy and metabolism in cancer. Arch Pharm Res 38(3):358–371. https://doi.org/10.1007/s12272-015-0562-2 CrossRefPubMed

126.

Goldsmith J, Levine B, Debnath J (2014) Autophagy and cancer metabolism. Methods Enzymol 542:25–57. https://doi.org/10.1016/b978-0-12-416618-9.00002-9 CrossRefPubMedPubMedCentral

127.

Brown RS, Wahl RL (1993) Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 72(10):2979–2985CrossRefPubMed

128.

Canpolat T, Ersoz C, Uguz A, Vardar MA, Altintas A (2016) GLUT-1 expression in proliferative endometrium, endometrial hyperplasia, endometrial adenocarcinoma and the relationship between GLUT-1 expression and prognostic parameters in endometrial adenocarcinoma. Turk Patoloji Derg 32(3):141–147. https://doi.org/10.5146/tjpath.2015.01352 CrossRefPubMed

129.

Cho H, Lee YS, Kim J, Chung JY, Kim JH (2013) Overexpression of glucose transporter-1 (GLUT-1) predicts poor prognosis in epithelial ovarian cancer. Cancer Investig 31(9):607–615. https://doi.org/10.3109/07357907.2013.849722 CrossRef

130.

Li CX, Sun JL, Gong ZC, Lin ZQ, Liu H (2016) Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: a prisma-compliant meta-analysis. Medicine (Baltimore) 95(45):e5324. https://doi.org/10.1097/md.0000000000005324 CrossRef

131.

Yang J, Wen J, Tian T, Lu Z, Wang Y, Wang Z, Wang X, Yang Y (2017) GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer. Oncotarget 8(7):11788–11796. https://doi.org/10.18632/oncotarget.14352 CrossRefPubMed

132.

Nagarajan A, Malvi P, Wajapeyee N (2016) Oncogene-directed alterations in cancer cell metabolism. Trends Cancer 2(7):365–377. https://doi.org/10.1016/j.trecan.2016.06.002 CrossRefPubMedPubMedCentral

133.

Boros LG, Torday JS, Lim S, Bassilian S, Cascante M, Lee WN (2000) Transforming growth factor beta2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res 60(5):1183–1185PubMed

134.

Marchiq I, Pouyssegur J (2016) Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters. J Mol Med 94(2):155–171. https://doi.org/10.1007/s00109-015-1307-x CrossRefPubMed

135.

Komohara Y, Takeya M (2017) CAFs and TAMs: maestros of the tumour microenvironment. J Pathol 241(3):313–315. https://doi.org/10.1002/path.4824 CrossRefPubMed

136.

Hashimoto O, Yoshida M, Koma Y, Yanai T, Hasegawa D, Kosaka Y, Nishimura N, Yokozaki H (2016) Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development. J Pathol 240(2):211–223. https://doi.org/10.1002/path.4769 CrossRefPubMedPubMedCentral

137.

Zhang A, Qian Y, Ye Z, Chen H, Xie H, Zhou L, Shen Y, Zheng S (2017) Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Cancer Med 6(2):463–470. https://doi.org/10.1002/cam4.993 CrossRefPubMedPubMedCentral

138.

Miyake M, Hori S, Morizawa Y, Tatsumi Y, Nakai Y, Anai S, Torimoto K, Aoki K, Tanaka N, Shimada K, Konishi N, Toritsuka M, Kishimoto T, Rosser CJ, Fujimoto K (2016) CXCL1-mediated interaction of cancer cells with tumor-associated macrophages and cancer-associated fibroblasts promotes tumor progression in human bladder cancer. Neoplasia 18(10):636–646. https://doi.org/10.1016/j.neo.2016.08.002 CrossRefPubMedPubMedCentral

139.

Comito G, Giannoni E, Segura CP, Barcellos-de-Souza P, Raspollini MR, Baroni G, Lanciotti M, Serni S, Chiarugi P (2014) Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene 33(19):2423–2431. https://doi.org/10.1038/onc.2013.191 CrossRefPubMed

140.

Kumar V, Donthireddy L, Marvel D, Condamine T, Wang F, Lavilla-Alonso S, Hashimoto A, Vonteddu P, Behera R, Goins MA, Mulligan C, Nam B, Hockstein N, Denstman F, Shakamuri S, Speicher DW, Weeraratna AT, Chao T, Vonderheide RH, Languino LR, Ordentlich P, Liu Q, Xu X, Lo A, Pure E, Zhang C, Loboda A, Sepulveda MA, Snyder LA, Gabrilovich DI (2017) Cancer-associated fibroblasts neutralize the anti-tumor effect of CSF1 receptor blockade by inducing PMN-MDSC infiltration of tumors. Cancer Cell 32(5):654–668.e655. https://doi.org/10.1016/j.ccell.2017.10.005 CrossRefPubMedPubMedCentral

141.

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden G, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O’Toole S, Larsimont D, de Wind R, Curigliano G, Andre F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB (2017) Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immuno-oncology biomarkers working group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors. Adv Anat Pathol. https://doi.org/10.1097/PAP.0000000000000161

142.

Reiser J, Banerjee A (2016) Effector, memory, and dysfunctional CD8(+) T cell fates in the antitumor immune response. J Immunol Res 2016:8941260. https://doi.org/10.1155/2016/8941260 CrossRefPubMedPubMedCentral

143.

Kamphorst JJ, Gottlieb E (2016) Cancer metabolism: friendly neighbours feed tumour cells. Nature 536(7617):401–402. https://doi.org/10.1038/nature19420 CrossRefPubMed

144.

Abu Aboud O, Habib SL, Trott J, Stewart B, Liang S, Chaudhari AJ, Sutcliffe J, Weiss RH (2017) Glutamine addiction in kidney cancer suppresses oxidative stress and can be exploited for real-time imaging. Cancer Res 77(23):6746–6758. https://doi.org/10.1158/0008-5472.Can-17-0930 CrossRefPubMed

145.

Niklison-Chirou MV, Erngren I, Engskog M, Haglof J, Picard D, Remke M, McPolin PHR, Selby M, Williamson D, Clifford SC, Michod D, Hadjiandreou M, Arvidsson T, Pettersson C, Melino G, Marino S (2017) TAp73 is a marker of glutamine addiction in medulloblastoma. Genes Dev 31(17):1738–1753. https://doi.org/10.1101/gad.302349.117 CrossRefPubMedPubMedCentral

146.

Finicle BT, Jayashankar V, Edinger AL (2018) Nutrient scavenging in cancer. Nat Rev Cancer 18(10):619–633. https://doi.org/10.1038/s41568-018-0048-x CrossRefPubMed

147.

Fais S, Overholtzer M (2018) Cell-in-cell phenomena in cancer. Nat Rev Cancer 18(12):758–766. https://doi.org/10.1038/s41568-018-0073-9 CrossRefPubMed

148.

Zhang Y, Ertl HC (2016) Starved and asphyxiated: how can CD8(+) T cells within a tumor microenvironment prevent tumor progression. Front Immunol 7:32. https://doi.org/10.3389/fimmu.2016.00032 CrossRefPubMedPubMedCentral

149.

Patsoukis N, Bardhan K, Chatterjee P, Sari D, Liu B, Bell LN, Karoly ED, Freeman GJ, Petkova V, Seth P, Li L, Boussiotis VA (2015) PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun 6:6692–6692. https://doi.org/10.1038/ncomms7692 CrossRefPubMed

150.

Saeidi A, Zandi K, Cheok YY, Saeidi H, Wong WF, Lee CYQ, Cheong HC, Yong YK, Larsson M, Shankar EM (2018) T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses. Front Immunol 9:2569. https://doi.org/10.3389/fimmu.2018.02569 CrossRefPubMedPubMedCentral

151.

Darvin P, Toor SM, Sasidharan Nair V, Elkord E (2018) Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med 50(12):165–165. https://doi.org/10.1038/s12276-018-0191-1 CrossRefPubMedCentral

152.

Palmer CS, Hussain T, Duette G, Weller TJ, Ostrowski M, Sada-Ovalle I, Crowe SM (2016) Regulators of glucose metabolism in CD4(+) and CD8(+) T cells. Int Rev Immunol 35(6):477–488. https://doi.org/10.3109/08830185.2015.1082178 CrossRefPubMed

153.

Chang CH, Qiu J, O’Sullivan D, Buck MD, Noguchi T, Curtis JD, Chen Q, Gindin M, Gubin MM, van der Windt GJ, Tonc E, Schreiber RD, Pearce EJ, Pearce EL (2015) Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 162(6):1229–1241. https://doi.org/10.1016/j.cell.2015.08.016 CrossRefPubMedPubMedCentral

154.

Cham CM, Driessens G, O’Keefe JP, Gajewski TF (2008) Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells. Eur J Immunol 38(9):2438–2450. https://doi.org/10.1002/eji.200838289 CrossRefPubMedPubMedCentral

155.

Turkcan S, Kiru L, Naczynski DJ, Sasportas LS, Pratx G (2019) Lactic acid accumulation in the tumor microenvironment suppresses (18)F-FDG uptake. Cancer Res 79(2):410–419. https://doi.org/10.1158/0008-5472.Can-17-0492 CrossRefPubMed

156.

Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3(3):177–185. https://doi.org/10.1016/j.cmet.2006.02.002 CrossRefPubMed

157.

Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3(3):187–197. https://doi.org/10.1016/j.cmet.2006.01.012 CrossRefPubMed

158.

Noman MZ, Hasmim M, Messai Y, Terry S, Kieda C, Janji B, Chouaib S (2015) Hypoxia: a key player in antitumor immune response. A review in the theme: cellular responses to hypoxia. Am J Phys Cell Physiol 309(9):C569–C579. https://doi.org/10.1152/ajpcell.00207.2015 CrossRef

159.

Larbi A, Zelba H, Goldeck D, Pawelec G (2010) Induction of HIF-1alpha and the glycolytic pathway alters apoptotic and differentiation profiles of activated human T cells. J Leukoc Biol 87(2):265–273. https://doi.org/10.1189/jlb.0509304 CrossRefPubMed

160.

Tao JH, Barbi J, Pan F (2015) Hypoxia-inducible factors in T lymphocyte differentiation and function. A review in the theme: cellular responses to hypoxia. Am J Phys Cell Physiol 309(9):C580–C589. https://doi.org/10.1152/ajpcell.00204.2015 CrossRef

161.

Takahashi S, Iizumi T, Mashima K, Abe T, Suzuki N (2014) Roles and regulation of ketogenesis in cultured astroglia and neurons under hypoxia and hypoglycemia. ASN Neuro 6(5). https://doi.org/10.1177/1759091414550997

162.

Sikalidis AK (2015) Amino acids and immune response: a role for cysteine, glutamine, phenylalanine, tryptophan and arginine in T-cell function and cancer? Pathol Oncol Res 21(1):9–17. https://doi.org/10.1007/s12253-014-9860-0 CrossRefPubMed

163.

Sukumar M, Roychoudhuri R, Restifo NP (2015) Nutrient competition: a new axis of tumor immunosuppression. Cell 162(6):1206–1208. https://doi.org/10.1016/j.cell.2015.08.064 CrossRefPubMedPubMedCentral

164.

Anderson KG, Stromnes IM, Greenberg PD (2017) Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies. Cancer Cell 31(3):311–325. https://doi.org/10.1016/j.ccell.2017.02.008 CrossRefPubMedPubMedCentral

165.

Poh AR, Ernst M (2018) Targeting macrophages in cancer: from bench to bedside. Front Oncol 8:49. https://doi.org/10.3389/fonc.2018.00049 CrossRefPubMedPubMedCentral

166.

Huang SC, Smith AM, Everts B, Colonna M, Pearce EL, Schilling JD, Pearce EJ (2016) Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity 45(4):817–830. https://doi.org/10.1016/j.immuni.2016.09.016 CrossRefPubMedPubMedCentral

167.

Liu D, Chang C, Lu N, Wang X, Lu Q, Ren X, Ren P, Zhao D, Wang L, Zhu Y, He F, Tang L (2017) Comprehensive proteomics analysis reveals metabolic reprogramming of tumor-associated macrophages stimulated by the tumor microenvironment. J Proteome Res 16(1):288–297. https://doi.org/10.1021/acs.jproteome.6b00604 CrossRefPubMed

168.

Netea-Maier RT, Smit JWA, Netea MG (2018) Metabolic changes in tumor cells and tumor-associated macrophages: a mutual relationship. Cancer Lett 413:102–109. https://doi.org/10.1016/j.canlet.2017.10.037 CrossRefPubMed

169.

Ocana MC, Martinez-Poveda B, Quesada AR, Medina MA (2018) Metabolism within the tumor microenvironment and its implication on cancer progression: an ongoing therapeutic target. Med Res Rev. https://doi.org/10.1002/med.21511

170.

Mazzone M, Menga A, Castegna A (2018) Metabolism and TAM functions—it takes two to tango. FEBS J 285(4):700–716. https://doi.org/10.1111/febs.14295 CrossRefPubMed

171.

Yan D, Adeshakin AO, Xu M, Afolabi LO, Zhang G, Chen YH, Wan X (2019) Lipid metabolic pathways confer the immunosuppressive function of myeloid-derived suppressor cells in tumor. Front Immunol 10:1399. https://doi.org/10.3389/fimmu.2019.01399 CrossRefPubMedPubMedCentral

172.

Eikawa S, Nishida M, Mizukami S, Yamazaki C, Nakayama E, Udono H (2015) Immune-mediated antitumor effect by type 2 diabetes drug, metformin. Proc Natl Acad Sci U S A 112(6):1809–1814. https://doi.org/10.1073/pnas.1417636112 CrossRefPubMedPubMedCentral

173.

Zarrouk M, Finlay DK, Foretz M, Viollet B, Cantrell DA (2014) Adenosine-mono-phosphate-activated protein kinase-independent effects of metformin in T cells. PLoS One 9(9):e106710. https://doi.org/10.1371/journal.pone.0106710 CrossRefPubMedPubMedCentral

174.

Rao M, Dodoo E, Zumla A, Maeurer M (2019) Immunometabolism and pulmonary infections: implications for protective immune responses and host-directed therapies. Front Microbiol 10:962. https://doi.org/10.3389/fmicb.2019.00962 CrossRefPubMedPubMedCentral

175.

De Vita MV, Scolfaro C, Santini B, Lezo A, Gobbi F, Buonfrate D, Kimani-Murage EW, Macharia T, Wanjohi M, Rovarini JM, Morino G (2019) Malnutrition, morbidity and infection in the informal settlements of Nairobi, Kenya: an epidemiological study. Ital J Pediatr 45(1):12. https://doi.org/10.1186/s13052-019-0607-0 CrossRefPubMedPubMedCentral

176.

Ibrahim MK, Zambruni M, Melby CL, Melby PC (2017) Impact of childhood malnutrition on host defense and infection. Clin Microbiol Rev 30(4):919–971. https://doi.org/10.1128/cmr.00119-16 CrossRefPubMedPubMedCentral

177.

DeBoer MD, Scharf RJ, Leite AM, Ferrer A, Havt A, Pinkerton R, Lima AA, Guerrant RL (2017) Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition. Nutrition 33:248–253. https://doi.org/10.1016/j.nut.2016.06.013 CrossRefPubMedPubMedCentral

178.

Das D, Grais RF, Okiro EA, Stepniewska K, Mansoor R, van der Kam S, Terlouw DJ, Tarning J, Barnes KI, Guerin PJ (2018) Complex interactions between malaria and malnutrition: a systematic literature review. BMC Med 16(1):186. https://doi.org/10.1186/s12916-018-1177-5 CrossRefPubMedPubMedCentral

179.

Martin SJ, Sabina EP (2019) Malnutrition and associated disorders in tuberculosis and its therapy. J Diet Suppl 16(5):602–610. https://doi.org/10.1080/19390211.2018.1472165 CrossRefPubMed

180.

Scrimshaw NS, SanGiovanni JP (1997) Synergism of nutrition, infection, and immunity: an overview. Am J Clin Nutr 66(2):464s–477s. https://doi.org/10.1093/ajcn/66.2.464S CrossRefPubMed

181.

Kishton RJ, Sukumar M, Restifo NP (2017) Metabolic regulation of T cell longevity and function in tumor immunotherapy. Cell Metab 26(1):94–109. https://doi.org/10.1016/j.cmet.2017.06.016 CrossRefPubMedPubMedCentral

182.

Zukiewicz-Sobczak W, Wroblewska P, Zwolinski J, Chmielewska-Badora J, Adamczuk P, Krasowska E, Zagorski J, Oniszczuk A, Piatek J, Silny W (2014) Obesity and poverty paradox in developed countries. Ann Agric Environ Med 21(3):590–594. https://doi.org/10.5604/12321966.1120608 CrossRefPubMed

183.

Harrison CA, Taren D (2018) How poverty affects diet to shape the microbiota and chronic disease. Nat Rev Immunol 18(4):279–287. https://doi.org/10.1038/nri.2017.121 CrossRefPubMed

184.

Kumar H (2019) Immunity and its role in white plague and obesity. Int Rev Immunol 38(4):129–130. https://doi.org/10.1080/08830185.2019.1659528 CrossRefPubMed

185.

Green WD, Beck MA (2017) Obesity impairs the adaptive immune response to influenza virus. Ann Am Thorac Soc 14(Supplement_5):S406–s409. https://doi.org/10.1513/AnnalsATS.201706-447AW CrossRefPubMedPubMedCentral

186.

Tagliabue C, Principi N, Giavoli C, Esposito S (2016) Obesity: impact of infections and response to vaccines. Eur J Clin Microbiol Infect Dis 35(3):325–331. https://doi.org/10.1007/s10096-015-2558-8 CrossRefPubMed

187.

Beisel WR (1992) History of nutritional immunology: introduction and overview. J Nutr 122(3 Suppl):591–596. https://doi.org/10.1093/jn/122.suppl_3.591 CrossRefPubMed

188.

Scrimshaw NS, Taylor CE, Gordon JE (1959) Interactions of nutrition and infection. Am J Med Sci 237(3):367–403PubMed

189.

Scrimshaw NS, Taylor CE, Gordon JE (1969) Interactions of nutrition and infection. WHO Chron 23(8):369–374PubMed

190.

Scrimshaw NS (1966) Synergistic and antagonistic interactions of nutrition and infection. Fed Proc 25(6):1679–1681PubMed

191.

Scrimshaw NS (2003) Historical concepts of interactions, synergism and antagonism between nutrition and infection. J Nutr 133(1):316s–321s. https://doi.org/10.1093/jn/133.1.316S CrossRefPubMed

192.

Scrimshaw NS (2010) INCAP studies of nutrition and infection. Food Nutr Bull 31(1):54–67. https://doi.org/10.1177/156482651003100107 CrossRefPubMed

193.

Ghosh S, Pellett PL, Aw-Hassan A, Mouneime Y, Smriga M, Scrimshaw NS (2008) Impact of lysine-fortified wheat flour on morbidity and immunologic variables among members of rural families in northwest Syria. Food Nutr Bull 29(3):163–171. https://doi.org/10.1177/156482650802900302 CrossRefPubMed

194.

Ghosh S, Smriga M, Vuvor F, Suri D, Mohammed H, Armah SM, Scrimshaw NS (2010) Effect of lysine supplementation on health and morbidity in subjects belonging to poor peri-urban households in Accra, Ghana. Am J Clin Nutr 92(4):928–939. https://doi.org/10.3945/ajcn.2009.28834 CrossRefPubMed

195.

Scrimshaw NS (2010) INCAP studies of endemic goiter and its prevention. Food Nutr Bull 31(1):111–117. https://doi.org/10.1177/156482651003100111 CrossRefPubMed

196.

Scrimshaw NS (2010) The origin and development of INCAP. Food Nutr Bull 31(1):4–8. https://doi.org/10.1177/156482651003100102 CrossRefPubMed

197.

Scrimshaw NS (2010) History and early development of INCAP. J Nutr 140(2):394–396. https://doi.org/10.3945/jn.109.114694 CrossRefPubMed

198.

Scrimshaw NS, Viteri FE (2010) INCAP studies of kwashiorkor and marasmus. Food Nutr Bull 31(1):34–41. https://doi.org/10.1177/156482651003100105 CrossRefPubMed

199.

Scrimshaw NS (2007) Prologue: historical introduction. Immunonutrition in health and disease. Br J Nutr 98(Suppl 1):S3–S4. https://doi.org/10.1017/s0007114507833034 CrossRefPubMed

200.

Grimble RF (2005) Immunonutrition. Curr Opin Gastroenterol 21(2):216–222CrossRefPubMed

201.

Cangelosi MJ, Rodday AM, Saunders T, Cohen JT (2014) Evaluation of the economic burden of diseases associated with poor nutrition status. JPEN J Parenter Enteral Nutr 38(2 Suppl):35s–41s. https://doi.org/10.1177/0148607113514612 CrossRefPubMed

202.

Krawinkel MB (2012) Interaction of nutrition and infections globally: an overview. Ann Nutr Metab 61(Suppl 1):39–45. https://doi.org/10.1159/000345162 CrossRefPubMed

203.

Calder PC (2013) Feeding the immune system. Proc Nutr Soc 72(3):299–309. https://doi.org/10.1017/s0029665113001286 CrossRefPubMed

204.

Reilly SM, Saltiel AR (2017) Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol 13(11):633–643. https://doi.org/10.1038/nrendo.2017.90 CrossRefPubMed

205.

Jun JC, Devera R, Unnikrishnan D, Shin MK, Bevans-Fonti S, Yao Q, Rathore A, Younas H, Halberg N, Scherer PE, Polotsky VY (2017) Adipose HIF-1alpha causes obesity by suppressing brown adipose tissue thermogenesis. J Mol Med 95(3):287–297. https://doi.org/10.1007/s00109-016-1480-6 CrossRefPubMed

206.

Ryan S (2017) Adipose tissue inflammation by intermittent hypoxia: mechanistic link between obstructive sleep apnoea and metabolic dysfunction. J Physiol 595(8):2423–2430. https://doi.org/10.1113/jp273312 CrossRefPubMedPubMedCentral

207.

Takikawa A, Mahmood A, Nawaz A, Kado T, Okabe K, Yamamoto S, Aminuddin A, Senda S, Tsuneyama K, Ikutani M, Watanabe Y, Igarashi Y, Nagai Y, Takatsu K, Koizumi K, Imura J, Goda N, Sasahara M, Matsumoto M, Saeki K, Nakagawa T, Fujisaka S, Usui I, Tobe K (2016) HIF-1alpha in myeloid cells promotes adipose tissue remodeling toward insulin resistance. Diabetes 65(12):3649–3659. https://doi.org/10.2337/db16-0012 CrossRefPubMed

208.

Karki S, Ngo DTM, Farb MG, Park SY, Saggese SM, Hamburg NM, Carmine B, Hess DT, Walsh K, Gokce N (2017) WNT5A regulates adipose tissue angiogenesis via antiangiogenic VEGF-A165b in obese humans. Am J Physiol Heart Circ Physiol 313(1):H200–h206. https://doi.org/10.1152/ajpheart.00776.2016 CrossRefPubMedPubMedCentral

209.

Beigier-Bompadre M, Montagna GN, Kuhl AA, Lozza L, Weiner J 3rd, Kupz A, Vogelzang A, Mollenkopf HJ, Lowe D, Bandermann S, Dorhoi A, Brinkmann V, Matuschewski K, Kaufmann SHE (2017) Mycobacterium tuberculosis infection modulates adipose tissue biology. PLoS Pathog 13(10):e1006676. https://doi.org/10.1371/journal.ppat.1006676 CrossRefPubMedPubMedCentral

210.

Han SJ, Glatman Zaretsky A, Andrade-Oliveira V, Collins N, Dzutsev A, Shaik J, Morais da Fonseca D, Harrison OJ, Tamoutounour S, Byrd AL, Smelkinson M, Bouladoux N, Bliska JB, Brenchley JM, Brodsky IE, Belkaid Y (2017) White adipose tissue is a reservoir for memory T cells and promotes protective memory responses to infection. Immunity 47(6):1154–1168.e1156. https://doi.org/10.1016/j.immuni.2017.11.009 CrossRefPubMedPubMedCentral

211.

Hopkins BD, Goncalves MD, Cantley LC (2016) Obesity and Cancer mechanisms: cancer metabolism. J Clin Oncol 34(35):4277–4283. https://doi.org/10.1200/jco.2016.67.9712 CrossRefPubMedPubMedCentral

212.

Perna S, Peroni G, Faliva MA, Bartolo A, Naso M, Miccono A, Rondanelli M (2017) Sarcopenia and sarcopenic obesity in comparison: prevalence, metabolic profile, and key differences. A cross-sectional study in Italian hospitalized elderly. Aging Clin Exp Res 29(6):1249–1258. https://doi.org/10.1007/s40520-016-0701-8 CrossRefPubMed

213.

Sousa AS, Guerra RS, Fonseca I, Pichel F, Amaral TF (2015) Sarcopenia among hospitalized patients—a cross-sectional study. Clin Nutr 34(6):1239–1244. https://doi.org/10.1016/j.clnu.2014.12.015 CrossRefPubMed

214.

Lee DC, Shook RP, Drenowatz C, Blair SN (2016) Physical activity and sarcopenic obesity: definition, assessment, prevalence and mechanism. Future Sci OA 2(3):Fso127. https://doi.org/10.4155/fsoa-2016-0028 CrossRefPubMedPubMedCentral

215.

Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31(12):1539–1547. https://doi.org/10.1200/jco.2012.45.2722 CrossRefPubMed

216.

Liu J, Motoyama S, Sato Y, Wakita A, Kawakita Y, Saito H, Minamiya Y (2016) Decreased skeletal muscle mass after neoadjuvant therapy correlates with poor prognosis in patients with esophageal cancer. Anticancer Res 36(12):6677–6685. https://doi.org/10.21873/anticanres.11278 CrossRefPubMed

217.

Blauwhoff-Buskermolen S, Versteeg KS, de van der Schueren MA, den Braver NR, Berkhof J, Langius JA, Verheul HM (2016) Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer. J Clin Oncol 34(12):1339–1344. https://doi.org/10.1200/jco.2015.63.6043 CrossRefPubMed

218.

Cespedes Feliciano EM, Lee VS, Prado CM, Meyerhardt JA, Alexeeff S, Kroenke CH, Xiao J, Castillo AL, Caan BJ (2017) Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: the C-SCANS study. Cancer 123(24):4868–4877. https://doi.org/10.1002/cncr.30950 CrossRefPubMed

219.

Argiles JM (2017) The 2015 ESPEN sir David Cuthbertson lecture: inflammation as the driving force of muscle wasting in cancer. Clin Nutr 36(3):798–803. https://doi.org/10.1016/j.clnu.2016.05.010 CrossRefPubMed

220.

VanderVeen BN, Fix DK, Carson JA (2017) Disrupted skeletal muscle mitochondrial dynamics, mitophagy, and biogenesis during cancer cachexia: a role for inflammation. Oxidative Med Cell Longev 2017:3292087. https://doi.org/10.1155/2017/3292087 CrossRef

221.

Londhe P, Guttridge DC (2015) Inflammation induced loss of skeletal muscle. Bone 80:131–142. https://doi.org/10.1016/j.bone.2015.03.015 CrossRefPubMedPubMedCentral

222.

Kim J, Lee J (2017) Role of transforming growth factor-beta in muscle damage and regeneration: focused on eccentric muscle contraction. J Exerc Rehabil 13(6):621–626. https://doi.org/10.12965/jer.1735072.536 CrossRefPubMedPubMedCentral

223.

Flint TR, Fearon DT, Janowitz T (2017) Connecting the metabolic and immune responses to cancer. Trends Mol Med 23(5):451–464. https://doi.org/10.1016/j.molmed.2017.03.001 CrossRefPubMed

224.

Jezek J, Cooper KF, Strich R (2018) Reactive oxygen species and mitochondrial dynamics: the yin and yang of mitochondrial dysfunction and cancer progression. Antioxidants 7(1). https://doi.org/10.3390/antiox7010013

225.

Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107(6):931–936. https://doi.org/10.1038/bjc.2012.350 CrossRefPubMedPubMedCentral

226.

Pin F, Couch ME, Bonetto A (2018) Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition. Curr Opin Support Palliat Care 12(4):420–426. https://doi.org/10.1097/spc.0000000000000382 CrossRefPubMedPubMedCentral

227.

Hotamisligil GS (2017) Inflammation, metaflammation and immunometabolic disorders. Nature 542(7640):177–185. https://doi.org/10.1038/nature21363 CrossRefPubMed

228.

Walson JL, Berkley JA (2018) The impact of malnutrition on childhood infections. Curr Opin Infect Dis 31(3):231–236. https://doi.org/10.1097/qco.0000000000000448 CrossRefPubMedPubMedCentral

229.

Cunningham-Rundles S, Lin H, Ho-Lin D, Dnistrian A, Cassileth BR, Perlman JM (2009) Role of nutrients in the development of neonatal immune response. Nutr Rev 67(Suppl 2):S152–S163. https://doi.org/10.1111/j.1753-4887.2009.00236.x CrossRefPubMed

230.

Victora CG, Bahl R, Barros AJD, França GVA, Horton S, Krasevec J, Murch S, Sankar MJ, Walker N, Rollins NC (2016) Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387(10017):475–490. https://doi.org/10.1016/S0140-6736(15)01024-7 CrossRefPubMed

231.

Stechmiller JK (2010) Understanding the role of nutrition and wound healing. Nutr Clin Pract 25(1):61–68. https://doi.org/10.1177/0884533609358997 CrossRefPubMed

232.

Keller HH, Vesnaver E, Davidson B, Allard J, Laporte M, Bernier P, Payette H, Jeejeebhoy K, Duerksen D, Gramlich L (2014) Providing quality nutrition care in acute care hospitals: perspectives of nutrition care personnel. J Hum Nutr Diet 27(2):192–202. https://doi.org/10.1111/jhn.12170 CrossRefPubMed

233.

Rosen BS, Maddox PJ, Ray N (2013) A position paper on how cost and quality reforms are changing healthcare in America: focus on nutrition. JPEN J Parenter Enteral Nutr 37(6):796–801. https://doi.org/10.1177/0148607113492337 CrossRefPubMed

234.

Tappenden KA, Quatrara B, Parkhurst ML, Malone AM, Fanjiang G, Ziegler TR (2013) Critical role of nutrition in improving quality of care: an interdisciplinary call to action to address adult hospital malnutrition. Medsurg Nurs 22(3):147–165PubMed

235.

Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, Erickson N, Laviano A, Lisanti MP, Lobo DN, McMillan DC, Muscaritoli M, Ockenga J, Pirlich M, Strasser F, de van der Schueren M, Van Gossum A, Vaupel P, Weimann A (2017) ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr 36(5):1187–1196. https://doi.org/10.1016/j.clnu.2017.06.017 CrossRefPubMed

236.

Caillet P, Liuu E, Raynaud Simon A, Bonnefoy M, Guerin O, Berrut G, Lesourd B, Jeandel C, Ferry M, Rolland Y, Paillaud E (2017) Association between cachexia, chemotherapy and outcomes in older cancer patients: a systematic review. Clin Nutr 36(6):1473–1482. https://doi.org/10.1016/j.clnu.2016.12.003 CrossRefPubMed

237.

Fukuda Y, Yamamoto K, Hirao M, Nishikawa K, Maeda S, Haraguchi N, Miyake M, Hama N, Miyamoto A, Ikeda M, Nakamori S, Sekimoto M, Fujitani K, Tsujinaka T (2015) Prevalence of malnutrition among gastric cancer patients undergoing gastrectomy and optimal preoperative nutritional support for preventing surgical site infections. Ann Surg Oncol 22(Suppl 3):S778–S785. https://doi.org/10.1245/s10434-015-4820-9 CrossRefPubMed

238.

Kang MC, Kim JH, Ryu SW, Moon JY, Park JH, Park JK, Park JH, Baik HW, Seo JM, Son MW, Song GA, Shin DW, Shin YM, Ahn HY, Yang HK, Yu HC, Yun IJ, Lee JG, Lee JM, Lee JH, Lee TH, Yim H, Jeon HJ, Jung K, Jung MR, Jeong CY, Lim HS, Hong SK (2018) Prevalence of malnutrition in hospitalized patients: a multicenter cross-sectional study. J Korean Med Sci 33(2):e10. https://doi.org/10.3346/jkms.2018.33.e10 CrossRefPubMed

239.

Planas M, Alvarez-Hernandez J, Leon-Sanz M, Celaya-Perez S, Araujo K, Garcia de Lorenzo A (2016) Prevalence of hospital malnutrition in cancer patients: a sub-analysis of the PREDyCES(R) study. Support Care Cancer 24(1):429–435. https://doi.org/10.1007/s00520-015-2813-7 CrossRefPubMed

240.

Na BG, Han SS, Cho YA, Wie GA, Kim JY, Lee JM, Lee SD, Kim SH, Park SJ (2018) Nutritional status of patients with cancer: a prospective cohort study of 1,588 hospitalized patients. Nutr Cancer 70(8):1228–1236. https://doi.org/10.1080/01635581.2019.1578392 CrossRefPubMed

241.

Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, Luke JJ, Gajewski TF (2018) The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359(6371):104–108. https://doi.org/10.1126/science.aao3290 CrossRefPubMedPubMedCentral

242.

Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillere R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragon L, Jacquelot N, Qu B, Ferrere G, Clemenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359(6371):91–97. https://doi.org/10.1126/science.aan3706 CrossRefPubMed

243.

Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, Fleck JS, Voigt AY, Palleja A, Ponnudurai R, Sunagawa S, Coelho LP, Schrotz-King P, Vogtmann E, Habermann N, Nimeus E, Thomas AM, Manghi P, Gandini S, Serrano D, Mizutani S, Shiroma H, Shiba S, Shibata T, Yachida S, Yamada T, Waldron L, Naccarati A, Segata N, Sinha R, Ulrich CM, Brenner H, Arumugam M, Bork P, Zeller G (2019) Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med 25(4):679–689. https://doi.org/10.1038/s41591-019-0406-6 CrossRefPubMedPubMedCentral

244.

Cheung SG, Goldenthal AR, Uhlemann AC, Mann JJ, Miller JM, Sublette ME (2019) Systematic review of gut microbiota and major depression. Front Psychiatry 10:34. https://doi.org/10.3389/fpsyt.2019.00034 CrossRefPubMedPubMedCentral

245.

Lazar V, Ditu LM, Pircalabioru GG, Picu A, Petcu L, Cucu N, Chifiriuc MC (2019) Gut microbiota, host organism, and diet trialogue in diabetes and obesity. Front Nutr 6:21. https://doi.org/10.3389/fnut.2019.00021 CrossRefPubMedPubMedCentral

246.

Lee KH, Gordon A, Shedden K, Kuan G, Ng S, Balmaseda A, Foxman B (2019) The respiratory microbiome and susceptibility to influenza virus infection. PLoS One 14(1):e0207898. https://doi.org/10.1371/journal.pone.0207898 CrossRefPubMedPubMedCentral

247.

Namasivayam S, Sher A, Glickman MS, Wipperman MF (2018) The microbiome and tuberculosis: early evidence for cross talk. MBio 9(5). https://doi.org/10.1128/mBio.01420-18

248.

Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL (2019) Separating host and microbiome contributions to drug pharmacokinetics and toxicity. Science 363(6427). https://doi.org/10.1126/science.aat9931

249.

Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, Sela DA, Muller AJ, Mullin JM, Albert K, Gilligan JP, DiGuilio K, Dilbarova R, Alexander W, Prendergast GC (2017) The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists. Cancer Res 77(8):1783–1812. https://doi.org/10.1158/0008-5472.Can-16-2929 CrossRefPubMedPubMedCentral

250.

Karl JP, Hatch AM, Arcidiacono SM, Pearce SC, Pantoja-Feliciano IG, Doherty LA, Soares JW (2018) Effects of psychological, environmental and physical stressors on the gut microbiota. Front Microbiol 9:2013. https://doi.org/10.3389/fmicb.2018.02013 CrossRefPubMedPubMedCentral

251.

Picca A, Fanelli F, Calvani R, Mule G, Pesce V, Sisto A, Pantanelli C, Bernabei R, Landi F, Marzetti E (2018) Gut dysbiosis and muscle aging: searching for novel targets against sarcopenia. Mediat Inflamm 2018:7026198. https://doi.org/10.1155/2018/7026198 CrossRef

252.

LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M (2013) Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 24(2):160–168. https://doi.org/10.1016/j.copbio.2012.08.005 CrossRefPubMed

253.

Mills S, Stanton C, Lane JA, Smith GJ, Ross RP (2019) Precision nutrition and the microbiome, part I: current state of the science. Nutrients 11(4). https://doi.org/10.3390/nu11040923

254.

Claesson MJ, Cusack S, O’Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, Stanton C, van Sinderen D, O’Connor M, Harnedy N, O’Connor K, Henry C, O’Mahony D, Fitzgerald AP, Shanahan F, Twomey C, Hill C, Ross RP, O’Toole PW (2011) Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 108(Suppl 1):4586–4591. https://doi.org/10.1073/pnas.1000097107 CrossRefPubMed

255.

Claesson MJ, Jeffery IB, Conde S, Power SE, O’Connor EM, Cusack S, Harris HM, Coakley M, Lakshminarayanan B, O’Sullivan O, Fitzgerald GF, Deane J, O’Connor M, Harnedy N, O’Connor K, O’Mahony D, van Sinderen D, Wallace M, Brennan L, Stanton C, Marchesi JR, Fitzgerald AP, Shanahan F, Hill C, Ross RP, O’Toole PW (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488(7410):178–184. https://doi.org/10.1038/nature11319 CrossRefPubMed

256.

Grosicki GJ, Fielding RA, Lustgarten MS (2018) Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle axis. Calcif Tissue Int 102(4):433–442. https://doi.org/10.1007/s00223-017-0345-5 CrossRefPubMed

257.

Singh RK, Chang HW, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH, Bhutani T, Liao W (2017) Influence of diet on the gut microbiome and implications for human health. J Transl Med 15(1):73. https://doi.org/10.1186/s12967-017-1175-y CrossRefPubMedPubMedCentral

258.

Romano KA, Vivas EI, Amador-Noguez D, Rey FE (2015) Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio 6(2):e02481. https://doi.org/10.1128/mBio.02481-14 CrossRefPubMedPubMedCentral

259.

Bibbo S, Ianiro G, Giorgio V, Scaldaferri F, Masucci L, Gasbarrini A, Cammarota G (2016) The role of diet on gut microbiota composition. Eur Rev Med Pharmacol Sci 20(22):4742–4749PubMed

260.

Coelho OGL, Candido FG, Alfenas RCG (2018) Dietary fat and gut microbiota: mechanisms involved in obesity control. Crit Rev Food Sci Nutr:1–9. https://doi.org/10.1080/10408398.2018.1481821

261.

Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052):105–108. https://doi.org/10.1126/science.1208344 CrossRefPubMedPubMedCentral

262.

Lopez-Legarrea P, Fuller NR, Zulet MA, Martinez JA, Caterson ID (2014) The influence of Mediterranean, carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state. Asia Pac J Clin Nutr 23(3):360–368. https://doi.org/10.6133/apjcn.2014.23.3.16 CrossRefPubMed

263.

Biesalski HK (2016) Nutrition meets the microbiome: micronutrients and the microbiota. Ann N Y Acad Sci 1372(1):53–64. https://doi.org/10.1111/nyas.13145 CrossRefPubMed

264.

Subramanian S, Huq S, Yatsunenko T, Haque R, Mahfuz M, Alam MA, Benezra A, DeStefano J, Meier MF, Muegge BD, Barratt MJ, VanArendonk LG, Zhang Q, Province MA, Petri WA Jr, Ahmed T, Gordon JI (2014) Persistent gut microbiota immaturity in malnourished Bangladeshi children. Nature 510(7505):417–421. https://doi.org/10.1038/nature13421 CrossRefPubMedPubMedCentral

265.

Clooney AG, Sutton TDS, Shkoporov AN, Holohan RK, Daly KM, O’Regan O, Ryan FJ, Draper LA, Plevy SE, Ross RP, Hill C (2019) Whole-virome analysis sheds light on viral dark matter in inflammatory bowel disease. Cell Host Microbe 26(6):764–778 e765. https://doi.org/10.1016/j.chom.2019.10.009 CrossRefPubMed

266.

Shkoporov AN, Clooney AG, Sutton TDS, Ryan FJ, Daly KM, Nolan JA, McDonnell SA, Khokhlova EV, Draper LA, Forde A, Guerin E, Velayudhan V, Ross RP, Hill C (2019) The human gut virome is highly diverse, stable, and individual specific. Cell Host Microbe 26(4):527–541 e525. https://doi.org/10.1016/j.chom.2019.09.009 CrossRefPubMed

267.

Tabatabaeizadeh SA, Tafazoli N, Ferns GA, Avan A, Ghayour-Mobarhan M (2018) Vitamin D, the gut microbiome and inflammatory bowel disease. J Res Med Sci 23:75. https://doi.org/10.4103/jrms.JRMS_606_17 CrossRefPubMedPubMedCentral

268.

Montoya D, Inkeles MS, Liu PT, Realegeno S, Teles RM, Vaidya P, Munoz MA, Schenk M, Swindell WR, Chun R, Zavala K, Hewison M, Adams JS, Horvath S, Pellegrini M, Bloom BR, Modlin RL (2014) IL-32 is a molecular marker of a host defense network in human tuberculosis. Sci Transl Med 6(250):250ra114. https://doi.org/10.1126/scitranslmed.3009546 CrossRefPubMedPubMedCentral

269.

Kuroda K, Okumura K, Isogai H, Isogai E (2015) The human cathelicidin antimicrobial peptide LL-37 and mimics are potential anticancer drugs. Front Oncol 5:144. https://doi.org/10.3389/fonc.2015.00144 CrossRefPubMedPubMedCentral

270.

Cuperus T, Kraaij MD, Zomer AL, van Dijk A, Haagsman HP (2018) Immunomodulation and effects on microbiota after in ovo administration of chicken cathelicidin-2. PLoS One 13(6):e0198188. https://doi.org/10.1371/journal.pone.0198188 CrossRefPubMedPubMedCentral

271.

Yoshimura T, McLean MH, Dzutsev AK, Yao X, Chen K, Huang J, Gong W, Zhou J, Xiang Y, J HB, O’Huigin C, Thovarai V, Tessarollo L, Durum SK, Trinchieri G, Bian XW, Wang JM (2018) The antimicrobial peptide CRAMP is essential for colon homeostasis by maintaining microbiota balance. J Immunol 200(6):2174–2185. https://doi.org/10.4049/jimmunol.1602073 CrossRefPubMed

272.

Dang AT, Marsland BJ (2019) Microbes, metabolites, and the gut-lung axis. Mucosal Immunol 12(4):843–850. https://doi.org/10.1038/s41385-019-0160-6 CrossRefPubMed

273.

Bacher P, Hohnstein T, Beerbaum E, Rocker M, Blango MG, Kaufmann S, Rohmel J, Eschenhagen P, Grehn C, Seidel K, Rickerts V, Lozza L, Stervbo U, Nienen M, Babel N, Milleck J, Assenmacher M, Cornely OA, Ziegler M, Wisplinghoff H, Heine G, Worm M, Siegmund B, Maul J, Creutz P, Tabeling C, Ruwwe-Glosenkamp C, Sander LE, Knosalla C, Brunke S, Hube B, Kniemeyer O, Brakhage AA, Schwarz C, Scheffold A (2019) Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans. Cell 176(6):1340–1355.e1315. https://doi.org/10.1016/j.cell.2019.01.041 CrossRefPubMed

274.

Mjosberg J, Rao A (2018) Lung inflammation originating in the gut. Science 359(6371):36–37. https://doi.org/10.1126/science.aar4301 CrossRefPubMed

275.

Baktash A, Terveer EM, Zwittink RD, Hornung BVH, Corver J, Kuijper EJ, Smits WK (2018) Mechanistic insights in the success of fecal microbiota transplants for the treatment of Clostridium difficile infections. Front Microbiol 9:1242. https://doi.org/10.3389/fmicb.2018.01242 CrossRefPubMedPubMedCentral

276.

Hudson LE, Anderson SE, Corbett AH, Lamb TJ (2017) Gleaning insights from fecal microbiota transplantation and probiotic studies for the rational design of combination microbial therapies. Clin Microbiol Rev 30(1):191–231. https://doi.org/10.1128/cmr.00049-16 CrossRefPubMed

277.

Hughes RL, Marco ML, Hughes JP, Keim NL, Kable ME (2019) The role of the gut microbiome in predicting response to diet and the development of precision nutrition models-part I: overview of current methods. Adv Nutr. https://doi.org/10.1093/advances/nmz022

278.

Aversa Z, Costelli P, Muscaritoli M (2017) Cancer-induced muscle wasting: latest findings in prevention and treatment. Ther Adv Med Oncol 9(5):369–382. https://doi.org/10.1177/1758834017698643 CrossRefPubMedPubMedCentral

279.

Fukawa T, Yan-Jiang BC, Min-Wen JC, Jun-Hao ET, Huang D, Qian CN, Ong P, Li Z, Chen S, Mak SY, Lim WJ, Kanayama HO, Mohan RE, Wang RR, Lai JH, Chua C, Ong HS, Tan KK, Ho YS, Tan IB, Teh BT, Shyh-Chang N (2016) Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia. Nat Med 22(6):666–671. https://doi.org/10.1038/nm.4093 CrossRefPubMed

280.

Sturgeon KM, Mathis KM, Rogers CJ, Schmitz KH, Waning DL (2019) Cancer- and chemotherapy-induced musculoskeletal degradation. JBMR Plus 3(3):e10187. https://doi.org/10.1002/jbm4.10187 CrossRefPubMedPubMedCentral

281.

Ikemoto S, Sugimura K, Yoshida N, Wada S, Yamamoto K, Kishimoto T (2000) TNF alpha, IL-1 beta and IL-6 production by peripheral blood monocytes in patients with renal cell carcinoma. Anticancer Res 20(1a):317–321PubMed

282.

Matthys P, Billiau A (1997) Cytokines and cachexia. Nutrition 13(9):763–770CrossRefPubMed

283.

Patel HJ, Patel BM (2017) TNF-alpha and cancer cachexia: molecular insights and clinical implications. Life Sci 170:56–63. https://doi.org/10.1016/j.lfs.2016.11.033 CrossRefPubMed

284.

Shyh-Chang N (2017) Metabolic changes during cancer cachexia pathogenesis. Adv Exp Med Biol 1026:233–249. https://doi.org/10.1007/978-981-10-6020-5_11 CrossRefPubMed

285.

Fearon KC, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16(2):153–166. https://doi.org/10.1016/j.cmet.2012.06.011 CrossRefPubMed

286.

Daas SI, Rizeq BR, Nasrallah GK (2018) Adipose tissue dysfunction in cancer cachexia. J Cell Physiol 234(1):13–22. https://doi.org/10.1002/jcp.26811 CrossRefPubMed

287.

Dalal S (2019) Lipid metabolism in cancer cachexia. Ann Palliat Med 8(1):13–23. https://doi.org/10.21037/apm.2018.10.01 CrossRefPubMed

288.

Sakuma K, Aoi W, Yamaguchi A (2017) Molecular mechanism of sarcopenia and cachexia: recent research advances. Pflugers Arch 469(5–6):573–591. https://doi.org/10.1007/s00424-016-1933-3 CrossRefPubMed

289.

Sandri M (2016) Protein breakdown in cancer cachexia. Semin Cell Dev Biol 54:11–19. https://doi.org/10.1016/j.semcdb.2015.11.002 CrossRefPubMed

290.

Liu Z, Sin KWT, Ding H, Doan HA, Gao S, Miao H, Wei Y, Wang Y, Zhang G, Li YP (2018) p38beta MAPK mediates ULK1-dependent induction of autophagy in skeletal muscle of tumor-bearing mice. Cell Stress 2(11):311–324. https://doi.org/10.15698/cst2018.11.163 CrossRefPubMedPubMedCentral

291.

Marzetti E, Lorenzi M, Landi F, Picca A, Rosa F, Tanganelli F, Galli M, Doglietto GB, Pacelli F, Cesari M, Bernabei R, Calvani R, Bossola M (2017) Altered mitochondrial quality control signaling in muscle of old gastric cancer patients with cachexia. Exp Gerontol 87(Pt A):92–99. https://doi.org/10.1016/j.exger.2016.10.003 CrossRefPubMed

292.

Pin F, Barreto R, Couch ME, Bonetto A, O’Connell TM (2019) Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism. J Cachexia Sarcopenia Muscle 10(1):140–154. https://doi.org/10.1002/jcsm.12360 CrossRefPubMedPubMedCentral

293.

Belloum Y, Rannou-Bekono F, Favier FB (2017) Cancer-induced cardiac cachexia: pathogenesis and impact of physical activity (review). Oncol Rep 37(5):2543–2552. https://doi.org/10.3892/or.2017.5542 CrossRefPubMed

294.

Coletti D (2018) Chemotherapy-induced muscle wasting: an update. Eur J Transl Myol 28(2):7587. https://doi.org/10.4081/ejtm.2018.7587 CrossRefPubMedPubMedCentral

295.

Moreira-Pais A, Ferreira R, Gil da Costa R (2018) Platinum-induced muscle wasting in cancer chemotherapy: mechanisms and potential targets for therapeutic intervention. Life Sci 208:1–9. https://doi.org/10.1016/j.lfs.2018.07.010 CrossRefPubMed

296.

Akyol M, Demir L, Alacacioglu A, Ellidokuz H, Kucukzeybek Y, Yildiz Y, Gumus Z, Bayoglu V, Yildiz I, Salman T, Varol U, Kucukzeybek B, Demir L, Dirican A, Sutcu R, Tarhan MO (2016) The effects of adjuvant endocrine treatment on serum leptin, serum adiponectin and body composition in patients with breast cancer: the Izmir Oncology Group (IZOG) Study. Chemotherapy 61(2):57–64. https://doi.org/10.1159/000440944 CrossRefPubMed

297.

Capozzi LC, McNeely ML, Lau HY, Reimer RA, Giese-Davis J, Fung TS, Culos-Reed SN (2016) Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: results from an exploratory randomized controlled exercise trial. Cancer 122(8):1185–1200. https://doi.org/10.1002/cncr.29863 CrossRefPubMed

298.

Pedersen B, Delmar C, Bendtsen MD, Bosaeus I, Carus A, Falkmer U, Groenkjaer M (2017) Changes in weight and body composition among women with breast cancer during and after adjuvant treatment: a prospective follow-up study. Cancer Nurs 40(5):369–376. https://doi.org/10.1097/ncc.0000000000000426 CrossRefPubMed

299.

Rier HN, Jager A, Sleijfer S, van Rosmalen J, Kock M, Levin MD (2018) Changes in body composition and muscle attenuation during taxane-based chemotherapy in patients with metastatic breast cancer. Breast Cancer Res Treat 168(1):95–105. https://doi.org/10.1007/s10549-017-4574-0 CrossRefPubMed

300.

Blackburn GL (1992) Nutrition and inflammatory events: highly unsaturated fatty acids (omega-3 vs omega-6) in surgical injury. Proc Soc Exp Biol Med 200(2):183–188. https://doi.org/10.3181/00379727-200-43414 CrossRefPubMed

301.

Grimble RF (1992) Dietary manipulation of the inflammatory response. Proc Nutr Soc 51(2):285–294CrossRefPubMed

302.

Lefkowith JB, Morrison A, Lee V, Rogers M (1990) Manipulation of the acute inflammatory response by dietary polyunsaturated fatty acid modulation. J Immunol 145(5):1523–1529PubMed

303.

Wan JM, Haw MP, Blackburn GL (1989) Nutrition, immune function, and inflammation: an overview. Proc Nutr Soc 48(3):315–335CrossRefPubMed

304.

Grimble RF (2001) Nutritional modulation of immune function. Proc Nutr Soc 60(3):389–397CrossRefPubMed

305.

Grimble RF (1994) Nutritional antioxidants and the modulation of inflammation: theory and practice. New Horiz 2(2):175–185PubMed

306.

Gostner JM, Becker K, Ueberall F, Fuchs D (2015) The good and bad of antioxidant foods: an immunological perspective. Food Chem Toxicol 80:72–79. https://doi.org/10.1016/j.fct.2015.02.012 CrossRefPubMed

307.

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hutterer E, Isenring E, Kaasa S, Krznaric Z, Laird B, Larsson M, Laviano A, Muhlebach S, Muscaritoli M, Oldervoll L, Ravasco P, Solheim T, Strasser F, de van der Schueren M, Preiser JC (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36(1):11–48. https://doi.org/10.1016/j.clnu.2016.07.015 CrossRefPubMed

308.

Çehrelli R (2018) Molecular nutritional immunology and cancer. J Oncol Sci 4:40–46CrossRef

309.

Grimble G (1994) Possible role of short-term parenteral nutrition with fat emulsions for development of haemophagocytosis with multiple organ failure in a patient with traumatic brain injury Roth B, Grande PO, Nillson-Ehle P and Eliasson I. Intensive Care Med 1993; 19: 111-114. Clin Nutr 13 (2):127

310.

Grimble G (1994) Can daily dietary arginine supplement affect the function and subpopulation of lymphocytes in patients with advanced gastric cancer? Wu C-W, Chi C-W, Chiu C-C, Liu W-Y, P’eng F-K and Wang S-R. Digestion 1993; 54: 118-124. Clin Nutr 13 (2):127–128

311.

Ramalho R, Ramalho P, Couto N, Pereira P (2017) Omega-3 therapeutic supplementation in a patient with metastatic adenocarcinoma of the pancreas with muscle mass depletion. Eur J Clin Nutr 71(6):795–797. https://doi.org/10.1038/ejcn.2017.47 CrossRefPubMed

312.

Burns CP, Halabi S, Clamon G, Kaplan E, Hohl RJ, Atkins JN, Schwartz MA, Wagner BA, Paskett E (2004) Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia. Cancer 101(2):370–378. https://doi.org/10.1002/cncr.20362 CrossRefPubMed

313.

Rosenthal MD, Carrott PW, Patel J, Kiraly L, Martindale RG (2016) Parenteral or enteral arginine supplementation safety and efficacy. J Nutr 146(12):2594s–2600s. https://doi.org/10.3945/jn.115.228544 CrossRefPubMed

314.

Mariette C (2015) Immunonutrition. J Visc Surg 152(Suppl 1):S14–S17. https://doi.org/10.1016/s1878-7886(15)30005-9 CrossRefPubMed

315.

Martin RC 2nd, Agle S, Schlegel M, Hayat T, Scoggins CR, McMasters KM, Philips P (2017) Efficacy of preoperative immunonutrition in locally advanced pancreatic cancer undergoing irreversible electroporation (IRE). Eur J Surg Oncol 43(4):772–779. https://doi.org/10.1016/j.ejso.2017.01.002 CrossRefPubMed

316.

Peker KD, Ozkanli SS, Akyuz C, Uzun O, Yasar NF, Duman M, Yol S (2017) Preoperative immunonutrition regulates tumor infiltrative lymphocytes and increases tumor angiogenesis in gastric cancer patients. Arch Med Sci 13(6):1365–1372. https://doi.org/10.5114/aoms.2016.60054 CrossRefPubMed

317.

Thornblade LW, Varghese TK Jr, Shi X, Johnson EK, Bastawrous A, Billingham RP, Thirlby R, Fichera A, Flum DR (2017) Preoperative immunonutrition and elective colorectal resection outcomes. Dis Colon Rectum 60(1):68–75. https://doi.org/10.1097/dcr.0000000000000740 CrossRefPubMedPubMedCentral

318.

Howes N, Atkinson C, Thomas S, Lewis SJ (2018) Immunonutrition for patients undergoing surgery for head and neck cancer. Cochrane Database Syst Rev 8:Cd010954. https://doi.org/10.1002/14651858.CD010954.pub2 CrossRefPubMed

319.

Mueller SA, Mayer C, Bojaxhiu B, Aeberhard C, Schuetz P, Stanga Z, Giger R (2019) Effect of preoperative immunonutrition on complications after salvage surgery in head and neck cancer. J Otolaryngol Head Neck Surg 48(1):25. https://doi.org/10.1186/s40463-019-0345-8 CrossRefPubMedPubMedCentral

320.

Song GM, Tian X, Liang H, Yi LJ, Zhou JG, Zeng Z, Shuai T, Ou YX, Zhang L, Wang Y (2015) Role of enteral immunonutrition in patients undergoing surgery for gastric cancer: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 94(31):e1311. https://doi.org/10.1097/md.0000000000001311 CrossRef

321.

Alito MA, de Aguilar-Nascimento JE (2016) Multimodal perioperative care plus immunonutrition versus traditional care in total hip arthroplasty: a randomized pilot study. Nutr J 15:34. https://doi.org/10.1186/s12937-016-0153-1 CrossRefPubMedPubMedCentral

322.

Kamocki Z, Matowicka-Karna J, Gryko M, Zareba K, Kedra B, Kemona H (2013) The effect of perioperative immunonutrition on the phagocytic activity of blood platelets in advanced gastric cancer patients. Clin Dev Immunol 2013:435672. https://doi.org/10.1155/2013/435672 CrossRefPubMedPubMedCentral

323.

Plank LD, Mathur S, Gane EJ, Peng SL, Gillanders LK, McIlroy K, Chavez CP, Calder PC, McCall JL (2015) Perioperative immunonutrition in patients undergoing liver transplantation: a randomized double-blind trial. Hepatology 61(2):639–647. https://doi.org/10.1002/hep.27433 CrossRefPubMed

324.

Camp KM, Trujillo E (2014) Position of the academy of nutrition and dietetics: nutritional genomics. J Acad Nutr Diet 114(2):299–312. https://doi.org/10.1016/j.jand.2013.12.001 CrossRefPubMed

325.

Cui J, Zhou B, Ross SA, Zempleni J (2017) Nutrition, microRNAs, and human health. Adv Nutr 8(1):105–112. https://doi.org/10.3945/an.116.013839 CrossRefPubMedPubMedCentral

326.

Fenech MF (2014) Nutriomes and personalised nutrition for DNA damage prevention, telomere integrity maintenance and cancer growth control. Cancer Treat Res 159:427–441. https://doi.org/10.1007/978-3-642-38007-5_24 CrossRefPubMed

327.

Bordoni A, Capozzi F (2014) Foodomics for healthy nutrition. Curr Opin Clin Nutr Metab Care 17(5):418–424. https://doi.org/10.1097/mco.0000000000000089 CrossRefPubMed

328.

Ramos-Lopez O, Milagro FI, Allayee H, Chmurzynska A, Choi MS, Curi R, De Caterina R, Ferguson LR, Goni L, Kang JX, Kohlmeier M, Marti A, Moreno LA, Perusse L, Prasad C, Qi L, Reifen R, Riezu-Boj JI, San-Cristobal R, Santos JL, Martinez JA (2017) Guide for current nutrigenetic, nutrigenomic, and nutriepigenetic approaches for precision nutrition involving the prevention and management of chronic diseases associated with obesity. J Nutrigenet Nutrigenomics 10(1–2):43–62. https://doi.org/10.1159/000477729 CrossRefPubMed

329.

Remely M, Stefanska B, Lovrecic L, Magnet U, Haslberger AG (2015) Nutriepigenomics: the role of nutrition in epigenetic control of human diseases. Curr Opin Clin Nutr Metab Care 18(4):328–333. https://doi.org/10.1097/mco.0000000000000180 CrossRefPubMed

330.

Minihane AM, Khan S, Leigh-Firbank EC, Talmud P, Wright JW, Murphy MC, Griffin BA, Williams CM (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 20(8):1990–1997CrossRefPubMed

331.

Grimble RF, Howell WM, O’Reilly G, Turner SJ, Markovic O, Hirrell S, East JM, Calder PC (2002) The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am J Clin Nutr 76(2):454–459. https://doi.org/10.1093/ajcn/76.2.454 CrossRefPubMed

332.

Paoloni-Giacobino A, Grimble R, Pichard C (2003) Genomic interactions with disease and nutrition. Clin Nutr 22(6):507–514CrossRefPubMed

333.

Costa MD, Vieira de Melo CY, Amorim AC, Cipriano Torres Dde O, Dos Santos AC (2016) Association between nutritional status, inflammatory condition, and prognostic indexes with postoperative complications and clinical outcome of patients with gastrointestinal neoplasia. Nutr Cancer 68(7):1108–1114. https://doi.org/10.1080/01635581.2016.1206578 CrossRefPubMed

334.

Perez-Cruz E, Camacho-Limas CP (2017) Association of nutritional status and functional capacity in gastrointestinal cancer patients. Gac Med Mex 153(5):575–580. https://doi.org/10.24875/gmm.17002776 CrossRefPubMed

335.

Wang Y, Zheng J, Gao Z, Han X, Qiu F (2018) Investigation on nutritional risk assessment and nutritional support status of surgical patients with colorectal cancer. J buon 23(1):62–67PubMed

336.

Zhang L, Lu Y, Fang Y (2014) Nutritional status and related factors of patients with advanced gastrointestinal cancer. Br J Nutr 111(7):1239–1244. https://doi.org/10.1017/s000711451300367x CrossRefPubMed

337.

Guertin MH, Robitaille K, Pelletier JF, Duchesne T, Julien P, Savard J, Bairati I, Fradet V (2018) Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trial. BMC Cancer 18(1):64. https://doi.org/10.1186/s12885-017-3979-9 CrossRefPubMedPubMedCentral

338.

Kopeina GS, Senichkin VV, Zhivotovsky B (2017) Caloric restriction—a promising anti-cancer approach: from molecular mechanisms to clinical trials. Biochim Biophys Acta Rev Cancer 1867(1):29–41. https://doi.org/10.1016/j.bbcan.2016.11.002 CrossRefPubMed

339.

Lien EC, Lau AN, Vander Heiden MG (2019) Putting the K(+) in K(+)aloric restriction. Immunity 50(5):1129–1131. https://doi.org/10.1016/j.immuni.2019.04.016 CrossRefPubMed

340.

Vodnala SK, Eil R, Kishton RJ, Sukumar M, Yamamoto TN, Ha NH, Lee PH, Shin M, Patel SJ, Yu Z, Palmer DC, Kruhlak MJ, Liu X, Locasale JW, Huang J, Roychoudhuri R, Finkel T, Klebanoff CA, Restifo NP (2019) T cell stemness and dysfunction in tumors are triggered by a common mechanism. Science 363(6434). https://doi.org/10.1126/science.aau0135

341.

Eil R, Vodnala SK, Clever D, Klebanoff CA, Sukumar M, Pan JH, Palmer DC, Gros A, Yamamoto TN, Patel SJ, Guittard GC, Yu Z, Carbonaro V, Okkenhaug K, Schrump DS, Linehan WM, Roychoudhuri R, Restifo NP (2016) Ionic immune suppression within the tumour microenvironment limits T cell effector function. Nature 537(7621):539–543. https://doi.org/10.1038/nature19364 CrossRefPubMedPubMedCentral

342.

Husson MO, Ley D, Portal C, Gottrand M, Hueso T, Desseyn JL, Gottrand F (2016) Modulation of host defence against bacterial and viral infections by omega-3 polyunsaturated fatty acids. J Inf Secur 73(6):523–535. https://doi.org/10.1016/j.jinf.2016.10.001 CrossRef

343.

McFarland CT, Fan YY, Chapkin RS, Weeks BR, McMurray DN (2008) Dietary polyunsaturated fatty acids modulate resistance to mycobacterium tuberculosis in Guinea pigs. J Nutr 138(11):2123–2128. https://doi.org/10.3945/jn.108.093740 CrossRefPubMedPubMedCentral

344.

Paul KP, Leichsenring M, Pfisterer M, Mayatepek E, Wagner D, Domann M, Sonntag HG, Bremer HJ (1997) Influence of n-6 and n-3 polyunsaturated fatty acids on the resistance to experimental tuberculosis. Metabolism 46(6):619–624. https://doi.org/10.1016/s0026-0495(97)90003-2 CrossRefPubMed

345.

Jordao L, Lengeling A, Bordat Y, Boudou F, Gicquel B, Neyrolles O, Becker PD, Guzman CA, Griffiths G, Anes E (2008) Effects of omega-3 and -6 fatty acids on Mycobacterium tuberculosis in macrophages and in mice. Microbes Infect 10(12–13):1379–1386. https://doi.org/10.1016/j.micinf.2008.08.004 CrossRefPubMed

346.

Grzybowski S, Dorken E (1983) Tuberculosis in Inuit. Ecol Dis 2(2):145–148PubMed

347.

Kilabuk E, Momoli F, Mallick R, Van Dyk D, Pease C, Zwerling A, Potvin SE, Alvarez GG (2019) Social determinants of health among residential areas with a high tuberculosis incidence in a remote Inuit community. J Epidemiol Community Health 73(5):401–406. https://doi.org/10.1136/jech-2018-211261 CrossRefPubMed

348.

Patterson M, Flinn S, Barker K (2018) Addressing tuberculosis among Inuit in Canada. Can Commun Dis Rep 44(3-4):82–85. https://doi.org/10.14745/ccdr.v44i34a02 CrossRefPubMedPubMedCentral

349.

Soh AZ, Chee CB, Wang YT, Yuan JM, Koh WP (2016) Dietary cholesterol increases the risk whereas PUFAs reduce the risk of active tuberculosis in Singapore Chinese. J Nutr 146(5):1093–1100. https://doi.org/10.3945/jn.115.228049 CrossRefPubMedPubMedCentral

350.

Ralph AP, Waramori G, Pontororing GJ, Kenangalem E, Wiguna A, Tjitra E, Sandjaja LDB, Yeo TW, Chatfield MD, Soemanto RK, Bastian I, Lumb R, Maguire GP, Eisman J, Price RN, Morris PS, Kelly PM, Anstey NM (2013) L-Arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS One 8(8):e70032. https://doi.org/10.1371/journal.pone.0070032 CrossRefPubMedPubMedCentral

351.

Schon T, Idh J, Westman A, Elias D, Abate E, Diro E, Moges F, Kassu A, Ayele B, Forslund T, Getachew A, Britton S, Stendahl O, Sundqvist T (2011) Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis—a randomised trial. Tuberculosis 91(5):370–377. https://doi.org/10.1016/j.tube.2011.06.002 CrossRefPubMed

352.

Behr FM, Chuwonpad A, Stark R, van Gisbergen K (2018) Armed and ready: transcriptional regulation of tissue-resident memory CD8 T cells. Front Immunol 9:1770. https://doi.org/10.3389/fimmu.2018.01770 CrossRefPubMedPubMedCentral

353.

Park SL, Gebhardt T, Mackay LK (2019) Tissue-resident memory T cells in cancer immunosurveillance. Trends Immunol 40(8):735–747. https://doi.org/10.1016/j.it.2019.06.002 CrossRefPubMed

354.

Li C, Zhu B, Son YM, Wang Z, Jiang L, Xiang M, Ye Z, Beckermann KE, Wu Y, Jenkins JW, Siska PJ, Vincent BG, Prakash YS, Peikert T, Edelson BT, Taneja R, Kaplan MH, Rathmell JC, Dong H, Hitosugi T, Sun J (2019) The transcription factor Bhlhe40 programs mitochondrial regulation of resident CD8(+) T cell fitness and functionality. Immunity 51(3):491–507.e497. https://doi.org/10.1016/j.immuni.2019.08.013 CrossRefPubMedPubMedCentral

355.

Milner JJ, Toma C, Yu B, Zhang K, Omilusik K, Phan AT, Wang D, Getzler AJ, Nguyen T, Crotty S, Wang W, Pipkin ME, Goldrath AW (2017) Runx3 programs CD8(+) T cell residency in non-lymphoid tissues and tumours. Nature 552(7684):253–257. https://doi.org/10.1038/nature24993 CrossRefPubMedPubMedCentral

356.

Mehta MM, Weinberg SE, Chandel NS (2017) Mitochondrial control of immunity: beyond ATP. Nat Rev Immunol 17(10):608–620. https://doi.org/10.1038/nri.2017.66 CrossRefPubMed

357.

Philip M, Schietinger A (2019) Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections. Curr Opin Immunol 58:98–103. https://doi.org/10.1016/j.coi.2019.04.014 CrossRefPubMedPubMedCentral

358.

Balmer ML, Ma EH, Bantug GR, Grahlert J, Pfister S, Glatter T, Jauch A, Dimeloe S, Slack E, Dehio P, Krzyzaniak MA, King CG, Burgener AV, Fischer M, Develioglu L, Belle R, Recher M, Bonilla WV, Macpherson AJ, Hapfelmeier S, Jones RG, Hess C (2016) Memory CD8(+) T cells require increased concentrations of acetate induced by stress for optimal function. Immunity 44(6):1312–1324. https://doi.org/10.1016/j.immuni.2016.03.016 CrossRefPubMed

359.

Narita T, Weinert BT, Choudhary C (2019) Functions and mechanisms of non-histone protein acetylation. Nat Rev Mol Cell Biol 20(3):156–174. https://doi.org/10.1038/s41580-018-0081-3 CrossRefPubMed

360.

Mashimo T, Pichumani K, Vemireddy V, Hatanpaa KJ, Singh DK, Sirasanagandla S, Nannepaga S, Piccirillo SG, Kovacs Z, Foong C, Huang Z, Barnett S, Mickey BE, DeBerardinis RJ, Tu BP, Maher EA, Bachoo RM (2014) Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell 159(7):1603–1614. https://doi.org/10.1016/j.cell.2014.11.025 CrossRefPubMedPubMedCentral

361.

Comerford SA, Huang Z, Du X, Wang Y, Cai L, Witkiewicz AK, Walters H, Tantawy MN, Fu A, Manning HC, Horton JD, Hammer RE, McKnight SL, Tu BP (2014) Acetate dependence of tumors. Cell 159(7):1591–1602. https://doi.org/10.1016/j.cell.2014.11.020 CrossRefPubMedPubMedCentral

362.

Wiens KE, Ernst JD (2016) The mechanism for type I interferon induction by Mycobacterium tuberculosis is bacterial strain-dependent. PLoS Pathog 12(8):e1005809. https://doi.org/10.1371/journal.ppat.1005809 CrossRefPubMedPubMedCentral

363.

McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A (2015) Type I interferons in infectious disease. Nat Rev Immunol 15(2):87–103. https://doi.org/10.1038/nri3787 CrossRefPubMedPubMedCentral

364.

Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, Quinn C, Blankenship D, Dhawan R, Cush JJ, Mejias A, Ramilo O, Kon OM, Pascual V, Banchereau J, Chaussabel D, O’Garra A (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466(7309):973–977. https://doi.org/10.1038/nature09247 CrossRefPubMedPubMedCentral

365.

Teles RM, Graeber TG, Krutzik SR, Montoya D, Schenk M, Lee DJ, Komisopoulou E, Kelly-Scumpia K, Chun R, Iyer SS, Sarno EN, Rea TH, Hewison M, Adams JS, Popper SJ, Relman DA, Stenger S, Bloom BR, Cheng G, Modlin RL (2013) Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 339(6126):1448–1453. https://doi.org/10.1126/science.1233665 CrossRefPubMedPubMedCentral

366.

Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J, Derrick SC, Shi R, Kumar NP, Wei W, Yuan X, Zhang G, Cai Y, Babu S, Catalfamo M, Salazar AM, Via LE, Barry CE 3rd, Sher A (2014) Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511(7507):99–103. https://doi.org/10.1038/nature13489 CrossRefPubMedPubMedCentral

367.

Wu J, Sun L, Chen X, Du F, Shi H, Chen C, Chen ZJ (2013) Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339(6121):826–830. https://doi.org/10.1126/science.1229963 CrossRefPubMed

368.

West AP, Shadel GS, Ghosh S (2011) Mitochondria in innate immune responses. Nat Rev Immunol 11(6):389–402. https://doi.org/10.1038/nri2975 CrossRefPubMedPubMedCentral

369.

Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417(1):1–13. https://doi.org/10.1042/BJ20081386 CrossRefPubMed

370.

Weinberg SE, Sena LA, Chandel NS (2015) Mitochondria in the regulation of innate and adaptive immunity. Immunity 42(3):406–417. https://doi.org/10.1016/j.immuni.2015.02.002 CrossRefPubMedPubMedCentral

371.

Cumming BM, Addicott KW, Adamson JH, Steyn AJ (2018) Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages. Elife:7. https://doi.org/10.7554/eLife.39169

372.

Tully G, Kortsik C, Hohn H, Zehbe I, Hitzler WE, Neukirch C, Freitag K, Kayser K, Maeurer MJ (2005) Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J Immunol 174(4):2174–2184. https://doi.org/10.4049/jimmunol.174.4.2174 CrossRefPubMed

373.

Wong EA, Joslyn L, Grant NL, Klein E, Lin PL, Kirschner DE, Flynn JL (2018) Low levels of T cell exhaustion in tuberculous lung granulomas. Infect Immun 86(9). https://doi.org/10.1128/IAI.00426-18

374.

Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y (2007) Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol 178(1):93–105. https://doi.org/10.1083/jcb.200703099 CrossRefPubMedPubMedCentral

375.

Perez-Escuredo J, Dadhich RK, Dhup S, Cacace A, Van Hee VF, De Saedeleer CJ, Sboarina M, Rodriguez F, Fontenille MJ, Brisson L, Porporato PE, Sonveaux P (2016) Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle 15(1):72–83. https://doi.org/10.1080/15384101.2015.1120930 CrossRefPubMed

376.

Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458(7239):762–765. https://doi.org/10.1038/nature07823 CrossRefPubMedPubMedCentral

377.

Yang C, Sudderth J, Dang T, Bachoo RM, McDonald JG, DeBerardinis RJ (2009) Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res 69(20):7986–7993. https://doi.org/10.1158/0008-5472.Can-09-2266 CrossRefPubMedPubMedCentral

378.

Metallo CM, Gameiro PA, Bell EL, Mattaini KR, Yang J, Hiller K, Jewell CM, Johnson ZR, Irvine DJ, Guarente L, Kelleher JK, Vander Heiden MG, Iliopoulos O, Stephanopoulos G (2011) Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481(7381):380–384. https://doi.org/10.1038/nature10602 CrossRefPubMedPubMedCentral

379.

Wang YP, Zhou W, Wang J, Huang X, Zuo Y, Wang TS, Gao X, Xu YY, Zou SW, Liu YB, Cheng JK, Lei QY (2016) Arginine methylation of MDH1 by CARM1 inhibits glutamine metabolism and suppresses pancreatic cancer. Mol Cell 64(4):673–687. https://doi.org/10.1016/j.molcel.2016.09.028 CrossRefPubMed

380.

Koppula P, Zhang Y, Zhuang L, Gan B (2018) Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun 38(1):12. https://doi.org/10.1186/s40880-018-0288-x CrossRef

381.

Goto M, Miwa H, Shikami M, Tsunekawa-Imai N, Suganuma K, Mizuno S, Takahashi M, Mizutani M, Hanamura I, Nitta M (2014) Importance of glutamine metabolism in leukemia cells by energy production through TCA cycle and by redox homeostasis. Cancer Investig 32(6):241–247. https://doi.org/10.3109/07357907.2014.907419 CrossRef

382.

Sugimoto K, Suzuki HI, Fujimura T, Ono A, Kaga N, Isobe Y, Sasaki M, Taka H, Miyazono K, Komatsu N (2015) A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines. Cancer Sci 106(11):1534–1543. https://doi.org/10.1111/cas.12807 CrossRefPubMedPubMedCentral

383.

Krall AS, Xu S, Graeber TG, Braas D, Christofk HR (2016) Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nat Commun 7:11457. https://doi.org/10.1038/ncomms11457 CrossRefPubMedPubMedCentral

384.

Sheen JH, Zoncu R, Kim D, Sabatini DM (2011) Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 19(5):613–628. https://doi.org/10.1016/j.ccr.2011.03.012 CrossRefPubMedPubMedCentral

385.

Scott L, Lamb J, Smith S, Wheatley DN (2000) Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cells. Br J Cancer 83(6):800–810. https://doi.org/10.1054/bjoc.2000.1353 CrossRefPubMedPubMedCentral

386.

Wang Z, Yip LY, Lee JHJ, Wu Z, Chew HY, Chong PKW, Teo CC, Ang HY, Peh KLE, Yuan J, Ma S, Choo LSK, Basri N, Jiang X, Yu Q, Hillmer AM, Lim WT, Lim TKH, Takano A, Tan EH, Tan DSW, Ho YS, Lim B, Tam WL (2019) Methionine is a metabolic dependency of tumor-initiating cells. Nat Med 25(5):825–837. https://doi.org/10.1038/s41591-019-0423-5 CrossRefPubMed

387.

Geck RC, Toker A (2016) Nonessential amino acid metabolism in breast cancer. Adv Biol Regul 62:11–17. https://doi.org/10.1016/j.jbior.2016.01.001 CrossRefPubMed

388.

Locasale JW (2013) Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer 13(8):572–583. https://doi.org/10.1038/nrc3557 CrossRefPubMedPubMedCentral

389.

Chaneton B, Hillmann P, Zheng L, Martin ACL, Maddocks ODK, Chokkathukalam A, Coyle JE, Jankevics A, Holding FP, Vousden KH, Frezza C, O’Reilly M, Gottlieb E (2012) Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491(7424):458–462. https://doi.org/10.1038/nature11540 CrossRefPubMedPubMedCentral

390.

Keenan MM, Chi JT (2015) Alternative fuels for cancer cells. Cancer J 21(2):49–55. https://doi.org/10.1097/ppo.0000000000000104 CrossRefPubMedPubMedCentral

391.

Schug ZT, Vande Voorde J, Gottlieb E (2016) The metabolic fate of acetate in cancer. Nat Rev Cancer 16(11):708–717. https://doi.org/10.1038/nrc.2016.87 CrossRefPubMedPubMedCentral

392.

Yoshii Y, Furukawa T, Saga T, Fujibayashi Y (2015) Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: overview and application. Cancer Lett 356(2 Pt A):211–216. https://doi.org/10.1016/j.canlet.2014.02.019 CrossRefPubMed

393.

Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, Orabona C, Bianchi R, Belladonna ML, Volpi C, Santamaria P, Fioretti MC, Puccetti P (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176(11):6752–6761. https://doi.org/10.4049/jimmunol.176.11.6752 CrossRefPubMed

394.

Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, Orabona C, Bianchi R, Belladonna ML, Volpi C, Fioretti MC, Puccetti P (2006) Tryptophan catabolism generates autoimmune-preventive regulatory T cells. Transpl Immunol 17(1):58–60. https://doi.org/10.1016/j.trim.2006.09.017 CrossRefPubMed

395.

Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL (2005) GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 22(5):633–642. https://doi.org/10.1016/j.immuni.2005.03.013 CrossRefPubMed

396.

Duffy AG, Melillo G, Turkbey B, Allen D, Choyke PL, Chen C, Raffeld M, Doroshow JH, Murgo A, Kummar S (2010) A pilot trial of oral topotecan (TPT) in patients with refractory advanced solid neoplasms expressing HIF-1α. J Clin Oncol 28(15_suppl):e13518–e13518. https://doi.org/10.1200/jco.2010.28.15_suppl.e13518 CrossRef

397.

Schilling B, Sucker A, Griewank K, Zhao F, Weide B, Gorgens A, Giebel B, Schadendorf D, Paschen A (2013) Vemurafenib reverses immunosuppression by myeloid derived suppressor cells. Int J Cancer 133(7):1653–1663. https://doi.org/10.1002/ijc.28168 CrossRefPubMed

398.

Beijer MR, Kraal G, den Haan JM (2014) Vitamin A and dendritic cell differentiation. Immunology 142(1):39–45. https://doi.org/10.1111/imm.12228 CrossRefPubMedPubMedCentral

399.

Cassani B, Villablanca EJ, De Calisto J, Wang S, Mora JR (2012) Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Mol Asp Med 33(1):63–76. https://doi.org/10.1016/j.mam.2011.11.001 CrossRef

400.

Ida S, Hiki N, Cho H, Sakamaki K, Ito S, Fujitani K, Takiguchi N, Kawashima Y, Nishikawa K, Sasako M, Aoyama T, Honda M, Sato T, Nunobe S, Yoshikawa T (2017) Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer. Br J Surg 104(4):377–383. https://doi.org/10.1002/bjs.10417 CrossRefPubMed

401.

Miyata H, Yano M, Yasuda T, Yamasaki M, Murakami K, Makino T, Nishiki K, Sugimura K, Motoori M, Shiraishi O, Mori M, Doki Y (2017) Randomized study of the clinical effects of omega-3 fatty acid-containing enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. Nutrition 33:204–210. https://doi.org/10.1016/j.nut.2016.07.004 CrossRefPubMed

402.

Sorensen LS, Thorlacius-Ussing O, Rasmussen HH, Lundbye-Christensen S, Calder PC, Lindorff-Larsen K, Schmidt EB (2014) Effects of perioperative supplementation with omega-3 fatty acids on leukotriene B(4) and leukotriene B(5) production by stimulated neutrophils in patients with colorectal cancer: a randomized, placebo-controlled intervention trial. Nutrients 6(10):4043–4057. https://doi.org/10.3390/nu6104043 CrossRefPubMedPubMedCentral

403.

Mocellin MC, Pastore e Silva Jde A, Camargo Cde Q, Fabre ME, Gevaerd S, Naliwaiko K, Moreno YM, Nunes EA, Trindade EB (2013) Fish oil decreases C-reactive protein/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients. Lipids 48(9):879–888. https://doi.org/10.1007/s11745-013-3816-0 CrossRefPubMed

404.

Silva Jde A, Trindade EB, Fabre ME, Menegotto VM, Gevaerd S, Buss Zda S, Frode TS (2012) Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients. Nutr Cancer 64(2):267–273. https://doi.org/10.1080/01635581.2012.643133 CrossRefPubMed

405.

Bonatto SJ, Oliveira HH, Nunes EA, Pequito D, Iagher F, Coelho I, Naliwaiko K, Kryczyk M, Brito GA, Repka J, Saboia LV, Fukujima G, Calder PC, Fernandes LC (2012) Fish oil supplementation improves neutrophil function during cancer chemotherapy. Lipids 47(4):383–389. https://doi.org/10.1007/s11745-011-3643-0 CrossRefPubMed

406.

Trabal J, Leyes P, Forga M, Maurel J (2010) Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutr Hosp 25(5):736–740PubMed

407.

Rotovnik Kozjek N, Kompan L, Soeters P, Oblak I, Mlakar Mastnak D, Mozina B, Zadnik V, Anderluh F, Velenik V (2011) Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study. Clin Nutr 30(5):567–570. https://doi.org/10.1016/j.clnu.2011.06.003 CrossRefPubMed

408.

Seguin P, Locher C, Boudjema K, Hamon C, Mouchel C, Malledant Y, Bellissant E (2016) Effect of a perioperative nutritional supplementation with oral impact(R) in patients undergoing hepatic surgery for liver cancer: a prospective, placebo-controlled, randomized, double-blind study. Nutr Cancer 68(3):464–472. https://doi.org/10.1080/01635581.2016.1153670 CrossRefPubMed

409.

Marano L, Porfidia R, Pezzella M, Grassia M, Petrillo M, Esposito G, Braccio B, Gallo P, Boccardi V, Cosenza A, Izzo G, Di Martino N (2013) Clinical and immunological impact of early postoperative enteral immunonutrition after total gastrectomy in gastric cancer patients: a prospective randomized study. Ann Surg Oncol 20(12):3912–3918. https://doi.org/10.1245/s10434-013-3088-1 CrossRefPubMed

410.

Okamoto Y, Okano K, Izuishi K, Usuki H, Wakabayashi H, Suzuki Y (2009) Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg 33(9):1815–1821. https://doi.org/10.1007/s00268-009-0140-1 CrossRefPubMed

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Immunometabolism: new insights and lessons from antigen-directed cellular immune responses

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Update Innere Medizin

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2020

Towards new TB vaccines

Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases

Introduction: immunopathology of unresolved tropical diseases

Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs

Schistosomiasis—from immunopathology to vaccines